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ABSTRACT 
Structural and biochemical studies of the DNA replication initiation mechanism of the second 
chromosome of Vibrio cholerae 
By 
Natalia Orlova 
Advisor: Dr. David Jeruzalmi 
Transmission of genetic information through DNA replication is one of the key 
processes for any living organism. Despite the extensive effort put into studies of the 
mechanism of DNA replication, the understanding of the process on the molecular level 
is still incomplete. Specifically the molecular details of the very first events of DNA 
replication initiation are not sufficiently understood. 
The majority of bacteria possess a single circular chromosome, and in order to 
initiate DNA replication these organisms utilize a conserved system, consisting of a 
specific DNA sequence - replication origin, called oriC, and replication initiator protein 
DnaA. However, bacteria with multipartite genomes evolved distinct systems to initiate 
replication of secondary chromosomes. In Vibrio cholerae, and in related species, 
secondary chromosome replication requires specific origin of replication, OriCII, and 
unique initiator protein, RctB, which shares no sequence similarity with other initiator 
proteins.  
Previous structural studies of bacterial DNA replication initiation were conducted 
in two kinds of systems: bacterial primary chromosomes and bacterial plasmids; these 
studies have been challenging, and there are still many opened questions to date. No prior 
structural work was done in order to elucidate mechanism of DNA replication initiation 
	 v	
in secondary bacterial chromosomes, such as DNA replication initiation conducted by 
RctB-oriCII system. The work described in this dissertation is dedicated to structural 
studies of RctB-oriCII system. The structures of all four RctB domains were solved using 
X-ray crystallography and biophysical and biochemical analyses of RctB-DNA 
complexes were conducted. This work produced first structural view for the secondary 
chromosomal DNA replication initiation machinery and laid out a strong foundation for 
future structural studies of RctB-OriCII complexes.   
We demonstrate that RctB consists of four domains. The structure of its central 
two domains resembles that of several plasmid replication initiators. RctB contains at 
least three DNA binding winged helix turn helix motifs, and mutations within any of 
these severely compromise biological activity. In the structure, RctB adopts a head-to-
head dimeric configuration that likely reflects the arrangement in solution. Therefore, 
major structural reorganization must accompany complex formation on the head-to-tail 
array of binding sites in oriCII. These findings support the hypothesis that the second 
Vibrionaceae chromosome arose from an ancestral plasmid, and that RctB may have 
evolved additional regulatory features. 
The structural and biophysical data obtained in the course of this work allowed us 
to develop a model of the macromolecular complex that several molecules of RctB form 
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CHAPTER 1 – INTRODUCTION 
 
1.1 DNA REPLICATION IS A KEY PROCESS FOR ANY LIVING CELL  
The genetic code of any organism is stored in the DNA. DNA forms a very stable 
double-stranded structure, and the stability of its structure ensures the safety of the 
genetic code. DNA should remain double-stranded at all times to ensure the optimal 
stability of the structure and ultimately the safety of the genetic information.  
There is a limited number of naturally occurring events that require separation of 
the two DNA strands: replication, transcription, recombination, and repair. DNA 
replication is a process of critical importance for any living organism, since accurate 
transmission of genetic information is necessary for the survival of its species. If a DNA 
strand becomes damaged, the second strand will serve as a template for the reconstitution 
of the damaged strand. It is, therefore, not surprising that the initiation of DNA 
replication has to be tightly regulated to avoid unnecessary events of DNA strands 
separation. DNA replication is initiated when a specialized protein, an initiator, binds to a 
specific DNA locus, the replication origin (1). In different species, the initiator protein 
forms either a homomeric or heteromeric complex on the replication origin. After the 
complex has been fully assembled, another protein, a helicase, binds DNA and actively 
unwinds the DNA duplex (1). The overall mechanism of DNA replication initiation is 
similar in all organisms, but protein factors involved in the process vary.  
1.2 DNA REPLICATION INITIATION OF BACTERIAL CHROMOSOME 
Although, at the molecular level, the mechanism of DNA replication initiation is 
not completely understood, studies of the Escherichia coli chromosomal replication 
system provide insight into the process. In the Escherichia coli system, the origin of 
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replication is called oriC, and the initiator protein is DnaA. Initiation of DNA replication 
begins when several copies of the DnaA protein bind to oriC, which leads to the initial 
DNA strand separation. The DnaA protein is conserved among bacteria, suggesting that 
the chromosomal replication mechanism is similar in various bacterial species (1,2).  
E. coli and the majority of bacteria possess one single circular chromosome, 
however, this genomic organization is not universal. Some bacterial species have more 
than one chromosome, for example, Vibrio cholerae has two circular chromosomes (3). 
Replication initiation of the first, larger chromosome in V. cholerae, requires the 
conserved DnaA initiator. Unlike the larger chromosome, the smaller chromosome 
requires a unique initiator protein, RctB (3). The initiator protein for replication of the 
second chromosome is a unique factor, RctB (3).  
In addition to chromosomal DNA, bacteria have extrachromosomal DNA in the 
form of circular plasmids. Most plasmids encode a specific initiator protein, which is 
required for initiation of plasmid replication (4). Therefore, in total there are three 
different types of bacterial replication systems: replication system of the primary (most 
often the only) chromosome, replication system of the secondary chromosomes, and 
plasmid replication systems. 
The replication initiation of chromosomal DNA in bacteria with a single 
chromosome has been extensively studied (1). Very low-resolution electron microscopy 
data showed that a large discrete assembly forms on E. coli replication origin, oriC (5-7). 
A plethora of structural data is available for the replication initiator protein DnaA. The 
initiator, DnaA, consists of four domains: domain I is involved in an interaction with the 
helicase DnaB (8) and in self-oligomerization (9), domain II is represented by a flexible 
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linker, domain III is an ATPase domain and it is also mediates protein self-
oligomerization, and domain IV mediates DNA binding (8). A core DnaA fragment 
(domains III and IV) from A. aeolicus crystallized as a right-handed helical filament (8). 
The DnaA monomers in the filament structure contacted each other via a very extensive 
protein-protein interface suggesting biological relevance of the filamentous assembly 
found in the crystal. The current hypothesis states that the same kind of DnaA-DnaA 
interaction is present in the assembly on the replication origin.  
The current initiation model suggests that DnaA forms the same helical assembly 
as observed in the crystal on the replication origin and the double-stranded DNA is 
wrapped around that filament. The current model agrees with the positions of the DNA-
binding domains within the filament (8). When DnaA crystals containing the protein 
filament are incubated with single-stranded DNA (ssDNA) molecules, the ssDNA bound 
to the protein filament. The structure of DnaA crystals soaked with ssDNA was 
determined, and it revealed that the ssDNA was bound to an inner surface of the DnaA 
helical filament (10). Based on these data a complete model of the complex was proposed 
(Figure 1.1 A).  
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Figure 1.1 A. Model of a filament formed on oriC during replication initiation (11). The 
figure was extracted from (11). The left subcomplex unwinds DNA. IHF (integration host factor) binding 
draws the DNA close to the single-stranded DNA binding surface of the DnaA filament, DNA unwinds and 
is being fixed on the inner surface of the filament. It remains unclear whether or not the right subcomplex is 
part of a uniform continuous filament as shown above. The discontinuity in oriC binding sites and their 
different directionality (Figure 1.1B) do not agree with the formation of a uniform DnaA filament.  
B. OriC map (11,12). OriC contains a number of DnaA binding sites. Two different groups of 
sites clearly can be distinguished based on their directionality (red arrows above the sites). Strong binding 
sites are shown in red and weak binding sites are shown in blue. DUE is a DNA unwinding element. The 
purple arrow indicates the minimal region of oriC, which is sufficient for DNA replication initiation (13). 
 
Even though the proposed model provides an explanation of the mechanism of 
DNA replication initiation, the model still has a few caveats. For example, the left and 
right halves of E. coli OriC have arrays of binding sites that have the opposite 
directionality that is inconsistent with a model of a continuous filament that forms on the 
entire OriC (Figure 1.1 A and B) (12).   
Two halves of OriC are defined by two arrays of DnaA binding sites with 
opposite directionalities, and these arrays could in fact be separate units. N. Stepankiw et 
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al. demonstrated that only the left part of the OriC is required for bacterial viability 
(Figure 1.1 B, purple arrow) (13). When the right part of the OriC was completely 
deleted, the E. coli bacteria was viable; however, the growth rate was significantly 
affected, which demonstrates that the left part of OriC is sufficient for DNA replication 
to occur. Ozaki et al. proposed that DnaA forms two different subcomplexes on OriC. A 
subcomplex on the left part of OriC is required to unwind the DNA, while subcomplex of 
the right part of OriC was proposed to facilitate DnaB loading (11).  
Taken together, while the E. coli DNA replication initiation system is the most 
studied, the model explaining mechanism of its function is still incomplete. Additional 
structural information is required to explain inconsistencies in the model, and provide 
detailed mechanistic explanation of the DNA replication initiation.  
1.3 DNA REPLICATION INITIATION OF PLASMIDS 
The DNA replication initiation system differs between the plasmid system and the 
E. coli chromosomal system. Extrachromosomal DNA in the form of plasmids is present 
in many species (4). Similar to chromosomal DNA, plasmid DNA must be replicated. 
Plasmids replicate autonomously and control their own replication (4). In many plasmids, 
the origin of replication contains several repeated binding sites for the initiator protein; 
these binding sites are called iterons. The plasmid initiator protein is usually called Rep 
and it is encoded within the plasmid (4).  The replication origin in plasmids contains 
several binding sites for the Rep initiator protein, which suggests that Rep proteins form 
an oligomer on the DNA (14). The host DnaA protein is also required for initiation of 
plasmid DNA replication (4);  it has been  suggested that this is due to the ability of 
DnaA to load the helicase DnaB (4,15).  
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One notable feature of plasmid replication initiators is that their function is 
regulated by their oligomeric state. Rep proteins exist as head-to-head dimers in solution, 
which represent an inactive form that is repressing their own transcription. Rep has to 
monomerize, which is the active form, prior to binding to the replication origin (4,14-16). 
In agreement with this model, mutations disrupting the dimerization interface of some 
Rep proteins produce a high copy number phenotype, since a higher number of active 
monomeric Rep molecules are available for the DNA replication initiation (14). Unlike 
DnaA, plasmid initiators do not use ATP; however, it was proposed that ATP-
hydrolyzing chaperones are required to convert inactive dimeric Rep proteins into the 
active monomeric form (16).  
A crystal structure of the RepE initiator protein, from the F factor plasmid, bound 
to its iteron DNA, demonstrated that the initiator consists of two structurally similar 
DNA-binding domains. The domain similarity was not obvious from its amino acid 
sequence (15). Both domains of RepE bind to specific DNA sequences within the iteron, 
which results in DNA bending. It was proposed that the DNA bending introduced by 
initiator proteins leads to DNA melting; however, the detailed mechanism of DNA 
unwinding and the helicase loading remain unclear (15). The proposed multimeric 
assembly formed by RepE on the origin of replication is shown in figure 1.2 (14,15).  
 
Figure 1.2. Theoretical model of an assembly 
formed by RepE protein on the origin DNA. The 
figure was extracted from (15). Additional binding of 
DNA-remodeling protein HU is required for origin 
remodeling. Binding of four RepE molecules and one 
HU dimer bends DNA, causing DNA supercoiling, 
which leads to DNA unwinding in the AT-rich 
region. The presented model does not explain the 
details of DNA unwinding and the following helicase 
loading, which happens with the help of the host 
DnaA protein. 
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Another group determined that the structure of a dimer of the N-terminal domain 
of the pPS10 plasmid initiator RepA. The RepA structure revealed the dimerization 
interface of the initiator and explained why the dimer is inactive; upon dimerization, the 
N-terminal domain moves and loses its ability to bind DNA (14). However, the C-
terminal domain of RepA retains its ability to bind DNA. The head-to-head dimer binds 
to the promoter of the RepA gene using the two C-terminal domains and inhibits RepA’s 
own transcription (Figure 1.3)  (14) 
 
Figure 1.3. Proposed model of RepE autoregulation. The figure was extracted from (15). As a 
dimer, RepE is inactive in DNA replication initiation and is not capable of binding the iteron sequence.  
However, the dimer binds to promoter DNA and represses the initiator transcription. Chaperones DnaK, 
DnaJ, and GrpE activate RepE by promoting its monomerization. The RepE monomers bind to iteron 
sequences with two binding sites located at the N- and C-termini of the protein. 
 
1.4 DNA REPLICATION INITIATION IN EUKARYOTES 
The main difference between DNA replication initiation in bacteria and in 
eukaryotes is that, in eukaryotes, DNA replication starts at multiple origins. Unlike 
bacteria, which use DnaA protein to assemble a homomultimer, eukaryotes utilize a pre-
assembled multiprotein complex consisting of several subunits allowing for precise 
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regulation; which is crucial for efficient replication of multiple eukaryotic chromosomes 
once per cell cycle.   
The conserved multiprotein complex that serves as a replication initiator in 
eukaryotes is called the Origin Recognition Complex (ORC) (17). The ORC has six 
subunits, namedORC1 through ORC6. ORC1, ORC4, and ORC5 possess an ATP-
binding domain (1). ORC2 and ORC3 may have a diverged ATPase fold (1). The ORC 
binds to the origin DNA and directs loading of a helicase, which in eukaryotes is called 
the minichromosome maintenance (MCM) protein complex (17).  
There are three common features shared by bacterial DnaA initiator and 
eukaryotic initiator proteins. First, initiators form multimolecular complexes on the 
replication origin, either homomeric as prokaryotic DnaA or heteromeric as eukaryotic 
ORCs. Secondly, ATP binding and hydrolysis regulates the functions of these initiators; 
DnaA and the ORC subunits have ATPase activity (17). Lastly, bacterial DnaA initiator 
and eukaryotic initiators load a helicase onto the origin DNA. Replication initiation 
mechanisms in bacteria and eukaryotes have important differences as well. The eventual 
goal of an initiator protein is to load a helicase onto the origin DNA.  
1.5 DNA REPLICATION INITIATION OF A SECONDARY BACTERIAL 
CHROMOSOME 
It is important to study the various replication initiation systems, because it will 
explain the key principles of the replication initiation mechanism. The findings about a 
particular replication initiation system can guide the studies of the related systems. 
The present study is focused on examining the mechanism of DNA replication of 
the secondary chromosome in V. cholerae. Most bacteria possess a single circular 
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chromosome, but a minority of bacteria split their genome into several chromosomes. 
Vibrio species possess two circular chromosomes; DNA replication initiation of these 
two chromosomes is controlled by two independent systems. Replication of the 
secondary chromosome requires a specific initiator protein, RctB (18). RctB was 
previously shown to hydrolyze ATP (18), which would make it similar to DnaA. 
However, the amino acid sequence of RctB does not display a classical ATP binding 
motifs (Walker A, Walker B), and the X-ray structures of RctB domains that we describe 
in this dissertation did not reveal a canonical ATP-binding fold; therefore, the conclusion 
that RctB is capable of hydrolyzing ATP should be taken with caution. There is also a 
report that contradicts with the proposed effect of ATP for RctB affinity to origin DNA 
(19). At the same time, the secondary chromosomal DNA replication initiation system 
shares similarities with the plasmid replication system. There are six direct sequence 
repeats at the origin of replication of the secondary chromosome, and one DnaA binding 
site, which resembles the organization of plasmid replication origin (3), (20).   
The sequence and organization of the replication origin of the second 
chromosome of V. cholerae was determined (Figure 1.4). The elements required for DNA 
replication initiation are six directly repeated RctB binding sites, one DnaA binding site, 
and an AT-rich sequence; these elements form OriCIImin (21). The 12-mer binding sites 
have to be methylated in order to bind RctB (21). The chromosomal region located near 
OriCIImin is called inc, and it has a regulatory function. The inc region contains several 
RctB binding sites. The replication origin structure suggests that the multi-protein 
complex assembly responsible for replication initiation is formed by several RctB 
molecules on OriCIImin.  
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Figure 1.4. Architecture of the origin of DNA replication of the secondary chromosome (oriCII) 
from Vibrio cholerae. oriCII contains five distinct binding sites for the RctB initiator, named for their 
length: 12-mer (pink), 11-mer (cyan), 39-mer (black), 29-mer (purple) and the rctA-39-mer (teal). The 
oriCII-min segment contains six direct repeats of the 12-mer site, and is sufficient to direct replication 
initiation in the presence of RctB. The other RctB binding sites are proposed to serve regulatory purposes. 
The origin also contains binding sites for DnaA (light orange) and integration host factor (IHF, light 
green), and an A-T rich region (white) that is the locus of the initial melting at the origin. The numbered 
black bars represent the probes used for DNA binding EMSA assays. 
 
The purpose of the present research is to provide structural insights that would 
allow us to shed more light on the process of DNA replication initiation in the V. 
cholerae secondary chromosomal system.  
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The conserved DnaA-oriC system is used to initiate replication of primary 
chromosomes throughout the bacterial kingdom; however, bacteria with multipartite 
genomes evolved distinct systems to initiate replication of secondary chromosomes. In 
the cholera pathogen, Vibrio cholerae, and in related species, secondary chromosome 
replication requires the RctB initiator protein. Here, we show that RctB consists of four 
domains. The structure of its central two domains resembles that of several plasmid 
replication initiators. RctB contains at least three DNA binding winged helix turn helix 
motifs, and mutations within any of these severely compromise biological activity. In the 
structure, RctB adopts a head-to-head dimeric configuration that likely reflects the 
arrangement in solution. Therefore, major structural reorganization likely accompanies 
complex formation on the head-to-tail array of binding sites in oriCII. Our findings 
support the hypothesis that the second Vibrionaceae chromosome arose from an ancestral 




 Regulated initiation is a common feature of DNA replication systems of 
chromosomes. Although incompletely understood at the atomic level, studies in 
Escherichia coli and other bacterial model systems have yielded great insight into this 
critical process (11,12,22-27). Two molecular players play a central role in the current 
model: 1) the origin of DNA replication, a site on the chromosome where DNA synthesis 
begins, and 2) the initiator protein that recognizes segments of double-stranded (ds) and 
single-stranded (ss) DNA within the origin (22). In E. coli, where initiation of bacterial 
chromosomal replication has been extensively studied, binding of multiple DnaA initiator 
proteins (~53kD) to sites within the 245 bp oriC DNA sequence leads to assembly of a 
large multi-protein DNA complex (13,22,28). The DnaA-OriC complex mediates initial 
melting of origin DNA within an A-T rich segment of the origin (22,29,30); the resulting 
ssDNA is bound and stabilized by an oligomeric form of DnaA (10,11). Melted DNA at 
the origin serves as the entry point for the replicative helicase, and additional events lead 
to establishment of the replisome (31). Notably, DnaA is conserved in all bacteria (8), 
suggesting that the E. coli paradigm for initiation of chromosome replication applies 
throughout the bacterial kingdom. Furthermore, many elements of the bacterial paradigm 
can be discerned in the more elaborate replication systems found in eukaryotes (32-34).  
However, organization of the bacterial genome into the paradigmatic single 
circular chromosome found in E. coli is by no means universal. For example, the 
genomes of several bacterial families, including the Vibrionaceae and the related 
Photobacteriacea, are distributed across more than one chromosome (35). Relatively 
little is known about the factors and mechanisms that govern replication initiation of 
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secondary chromosomes in bacteria with multipartite genomes.  In Vibrio cholerae, the 
causative agent of cholera, replication of the larger primary chromosome (chrI) is 
managed by a DnaA-oriC system that closely resembles that of E. coli (3,21,36). In 
contrast, replication of the smaller secondary chromosome (chrII) is managed by a 
parallel system that contains unique components (3,21). Neither the chrII origin (oriCII), 
nor RctB, its cognate replication initiator protein, bear any sequence similarity to 
functional analogs utilized by characterized chromosome or plasmid replication systems 
(35).   
RctB is a highly conserved 75.3 kD protein (658 residues), which is unique to the 
Vibrionaceae, and shows no detectible relationship to any other protein in the sequence 
database. The first ~500 amino acids of RctB are sufficient to mediate oriCII-based 
replication (35,37,38) and its C-terminal 165 residues may mediate regulatory processes 
(35,37-39). The restriction of RctB to the Vibrionaceae, a large family of organisms that 
includes several important human and fish pathogens, suggests it as a potential target for 
discovery and design of novel selective antibacterial agents (40). 
The V. cholerae oriCII DNA element spans 887 base-pairs, and is organized into 
two functional domains (Figure 2.1) (39). These are: 1) a 367 bp segment (oriCII-min) 
that supports RctB-based replication of plasmids containing this sequence in V. cholerae 
and E. coli (21), and 2) an adjacent 520 bp segment (oriCIIinc), which exerts a negative 
regulatory role on oriCII-based replication (21,39). Both oriCIIinc and oriCII-min harbor 
a variety of sites, referred to as 12-mers, 11-mers, 39-mers, and 29-mers based on their 
lengths, which are known to bind RctB (21,35,41-43) (Table S 2.1). OriCII-min contains 
a 167 bp region that harbors six 12-mer sites, arranged with a regular spacing (10 or 11 
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bps apart) in a head-to-tail manner. Thus, six copies of RctB (or a multiple thereof) are 
expected to bind to oriCII-min, and associate into an oligomeric entity that should retain 
the head to tail configuration of the 12-mer sites. OriCII-min also contains a single 
binding site for DnaA, which is required for chrII replication (21). The remaining 190 bp 
of the oriCII-min element contains an A-T rich segment, which is likely melted to initiate 
replisome assembly (39), and a 29-mer RctB binding site that overlaps with the rctB 
promoter (43). Thorough mutational analysis of oriCII-min revealed high sensitivity to 
introduced changes (e.g. changes in the spacing between 12-mer binding sites impaired 
oriCII-based replication (39)).  
 
Figure 2.1. Architecture of the origin of DNA replication of the secondary chromosome (oriCII) 
from Vibrio cholerae. oriCII contains five distinct binding sites for the RctB initiator, named for their 
length: 12-mer (pink), 11-mer (cyan), 39-mer (black), 29-mer (purple) and the rctA-39-mer (teal). The 
oriCII-min segment contains six direct repeats of the 12-mer site, and is sufficient to direct replication 
initiation in the presence of RctB. The other RctB binding sites are proposed to serve regulatory purposes. 
The origin also contains binding sites for DnaA (light orange) and integration host factor (IHF, light 
green), and an A-T rich region (white) that is the locus of the initial melting at the origin. The numbered 
black bars represent the probes used for DNA binding EMSA assays. 
 
With a mass of 75.3 kDa, RctB is larger than other initiators for bacterial (DnaA: 
~53 kDa), or plasmid DNA replication (RepE: 29 kDa, π: 35 kDa), implying that the 
second V. cholerae initiator (DnaA is the first) may encode additional functions not found 
in other initiators. To gain insights into mechanisms implemented by RctB at oriCII, we 
describe biochemical and structural analyses of RctB. Our findings suggest that RctB is 
comprised of four structural domains. The two central domains of RctB are structurally 
related to the plasmid replication initiators RepE and π. However, RctB contains two 
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additional domains not found in the plasmid initiators, and we found that one of these 
domains is also critical for the initiator to bind to oriCII and mediate replication. The 
finding that the DNA binding surface of RctB is comprised of domains 1, 2, and 3 
provokes reexamination of models of binding to the array of 12-mers in oriCII-min.  The 
head-to-head dimeric configuration seen in the RctB structure is incompatible with 
binding to the head-to-tail arrangement of binding sites in oriCII; this suggests that 
dissociation and/or conformational switching in RctB dimers must accompany the 
initiator’s binding to oriCII.  
2.3 MATERIALS AND METHODS 
2.3.1 Plasmids 
The wild-type RctB expression construct has been described (35). Other RctB 
expression constructs were generated using conventional PCR-based cloning. Point 
mutants were generated using the QuikChange® II XL site-directed mutagenesis kit 
(Agilent). 
The oriCII-min transformation plasmid, as well as plasmids from which the 
EMSA probes corresponding to 1) the array of six 12-mer sites, 2) the inc11 site, and 3) 
the inc12 site were generated have been described (39). Plasmids containing the EMSA 
probes corresponding to the inc39 site, the rctA39 site, and the PrctB sites were generated 
by inserting the relevant dsDNA (Table S 2.4) into the SmaI restriction of pBlueScript II 
KS+.  
A complete list of plasmids, primers, and EMSA probes appears in supplementary 
tables 2.3, 2.4, and 2.5 respectively. The sequence of the insert in each plasmid was 
verified by DNA sequencing (Genewiz).   
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2.3.2 Protein biochemistry 
Proteins in this study were produced using standard methods for preparing 
recombinant proteins in bacteria (44). Expression plasmids for full length (35) and 
designed variants (Supplementary table 2.2) included C-terminal hexahistidine affinity 
tags; the full-length RctB constructs (wild type and the mutants), as well as the RctB-1-
499 constructs, contained an additional alanine in position 2 following the first 
methionine, and additional leucine and glutamic acid residues at the C-terminus 
preceding the hexahistidine affinity tag; RctB-2-124 and RctB-155-483 constructs 
contained the hexahistidine affinity tag only. All the expression plasmids were grown in 
E. coli BL21. Small-scale growths were performed in LB media supplemented with 50 
µg/mL kanamycin. Cultures were started by addition of an overnight ‘starter’ culture 
prepared from a fresh transformation at a 5% volume ratio of starter to culture volume. 
Cells were cultured at 37°C until their density reached at OD600 ≈ 0.6-0.7, the culture was 
cooled to approximately 20°C, and protein expression was induced by addition of 1 mM 
IPTG to the culture medium. Protein expression was allowed to continue at 16°C for 14-
18 hours. Cells were then harvested by centrifugation and resuspended in buffer A (500 
mM NaCl, 50 mM sodium phosphate (pH 8.0), 5% glycerol) at a ratio of 5 ml of buffer A 
per gram of cells. Large scale growths were carried out in a fermenter as above, except 
that SuperBroth (12 g/L tryptone, 24 g/L yeast extract, 2.3 g/L KH2PO4, 12.5 g/L 
K2HPO4, 3.2% glycerol), supplemented with 1 mM MgCl2, and 0.1 mM CaCl2 was used 
in place of LB, 100% oxygen was bubbled through the media at 0.5 – 1 L/min, and the 
agitation rate was set to 450 RPM. The culture was grown at 37°C until its density 
reached OD600 ≈ 2. Protein expression was induced by addition of 1 mM IPTG to the 
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media. Protein expression was allowed to proceed for 14-18 hours at 27°C. RctB proteins 
substituted with selenomethionine were prepared as described (45,46). 
RctB proteins used for electromobility shift assays (EMSAs) were expressed and 
purified as described previously (21,47). 
RctB proteins that were used for crystallization were purified using different 
purification protocols with a number of chromatography steps. The first purification step 
was common for all the purification protocols. The proteins were initially purified by 
thawing frozen biomass cells expressing the appropriate construct into Ni buffer A (500 
mM NaCl, 50 mM potassium phosphate, pH 8.0) such that a three-fold dilution was 
achieved. Cell lysis was achieved by sonication. The soluble fraction was then isolated by 
centrifugation and incubated with nickel-nitrilotriacetic acid (Ni-NTA) agarose 
(QIAGEN) for 40 min at 4°C.   
For RctB-2-124, the Ni-NTA agarose beads were washed with a set of buffer 
solutions with increasing imidazole concentration containing up to 40 mM imidazole; 
RctB-2-142 was then eluted by washing with 500 mM imidazole. The Ni-NTA purified 
material was diluted 5-fold (to achieve a final NaCl concentration of 100 mM) with Q-SP 
buffer A (20 mM Tris 7.4, 5% glycerol, 5 mM beta-mercaptoethanol), and applied to a Q 
column (Q Sepharose Fast Flow, GE Healthcare) arranged inline with an SP-column (SP 
Sepharose Fast Flow, GE Healthcare), both equilibrated with Q-SP buffer A. RctB was 
eluted from the SP column to which it bound using a gradient from 0.1 to 2 M sodium 
chloride. Fractions containing pure protein were dialyzed into the following buffer: 50 
mM sodium chloride, 20 mM Tris pH 7.4, 5% glycerol, 5 mM beta-mercaptoethanol, 
concentrated and either were used fresh or were flash-frozen in liquid nitrogen, and 
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stored until use. The yield was approximately 18 mg per liter of culture (3 mg of protein 
per 1 gram of cells). 
For RctB-2-124-L48M (selenomethionine labeled), the Ni-NTA agarose beads 
were washed with a set of buffer solutions with increasing imidazole concentration 
containing up to 40 mM imidazole; RctB-2-124-L48M was then eluted by washing with 
500 mM imidazole. The resulting Ni-NTA purified protein was concentrated, and applied 
to a size-exclusion column (Superdex 200 beads, GE healthcare). Chromatography was 
carried out in SEC buffer: 500 mM NaCl, 20 mM Tris pH 7.4, 5% glycerol, 5 mM beta-
mercaptoethanol. Fractions containing pure protein were concentrated, and either were 
used fresh or were flash-frozen in liquid nitrogen, and stored until use. The yield was 
approximately 18 mg per liter of culture (3 mg of protein per 1 gram of cells). 
For RctB-155-483 (selenomethionine labeled), the Ni-NTA agarose beads were 
washed with a set of buffer solutions with increasing imidazole concentration containing 
up to 60 mM imidazole, RctB-2-155-483 was then eluted with 500 mM imidazole. 
Fractions containing pure protein were pooled and brought to 1.4 M ammonium sulfate 
by addition of powder. Then protein was loaded onto butyl column (Macro-Prep® t-Butyl 
HIC Support, BIO-RAD), and eluted with reverse gradient of ammonium sulfate 
(gradient from 1.4 to 0.07 M ammonium sulfate). The fractions containing the pure 
protein were pooled, concentrated, and further purified using size-exclusion 
chromatography (Superdex 200 media, GE healthcare). The final buffer (SEC buffer) 
contained 500 mM NaCl, 10 mM Tris pH 7.4, 5% glycerol, 5 mM beta-mercaptoethanol. 
Fractions containing pure protein were concentrated, and either were used fresh or were 
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flash-frozen in liquid nitrogen, and stored until use. The yield was approximately 15 mg 
per liter of culture (2.5 mg of protein per 1 gram of cells). 
One measure of the integrity of point mutants of RctB, in comparison to wild-
type, was to assess solution properties by SEC (Figure S2.6). SEC was performed using a 
21.6 ml column packed with Superdex 200 prep grade (GE Healthcare) in the following 
buffer: 500 mM NaCl, 10 mM Tris-HCl pH 7.4, 5% glycerol, 5 mM 2-merceptoethanol. 
Estimates of the masses of various RctB proteins were obtained by comparing elution 
volumes against those by a set of molecular weight standards (GE Healthcare).  
2.3.3 Electrophoretic mobility shift assay 
Due to the requirement for methylated DNA (methylation at the N6 position of 
the adenine residues in the sequence GATC) for RctB binding (39), it was necessary to 
produce EMSA probes by excising them from methylated plasmid DNA. Probe 
fragments were cloned into the pBlueScript II SK(+) vector and the constructs were 
prepped from Dam(+) E. coli. The constructs were then digested with XbaI and XhoI and 
treated with CIP (NEB) for 2 hours at 37 0C. The digests were separated on 1% agarose 
gels and the probes were excised and extracted from the gel. The DNA was then desalted 
using Illustra MicroSpin G-50 Columns (GE) and the concentration was quantitated with 
a NanoDrop (ThermoFisher Scientific). The probe ends were then labeled with T4 PNK 
(NEB) and a slight excess of gamma P32 ATP. The probes were separated from the 
nucleotide using  Illustra MicroSpin G-50 Columns (GE). The labeled probes were then 
phenol-chloroform extracted and subjected to ethanol precipitation. 
Binding reactions were conducted in 20 µL of 1x EMSA reaction buffer: 20mM 
TrisCl pH 7.5, 1mM EDTA,150mM NaCl, 1mM MgCl2, 100 µg/mL BSA,12.5 µg/mL 
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poly (dI-dC). Radiolabeled probes were added to a final concentration of 0.1 nM. The 
reactions were incubated for 10 minutes at room temperature. 5 µL of 1x EMSA reaction 
buffer with 50% glycerol was added to the reactions, which were then loaded onto 6% 
DNA retardation gels (ThermoFisher Scientific) and run in 0.5% TBE buffer. The probes 
contained binding sites embedded in a larger DNA sequence, and for the complete 
sequence of the probes, please refer to table S 2.5. The gels were then dried onto filter 
paper and then exposed to a Phosphor Screen and imaged with Fuji FLA-5000 imager. 
Band intensities were quantified using Image Studio™ Lite software (LI-COR, Inc). The 
data was fit to appropriate binding equations using KaleidaGraph 4.5. 
2.3.4 Transformation Efficiency Assay 
The transformation assay was performed as previously described (35,39). To 
place the results of this assay on a quantitative basis, we noted that, when cells that 
harbored a plasmid expressing wild-type RctB were transformed with an oriCII-min 
containing plasmid, 200-300 colonies were obtained. Under these conditions, this number 
of colonies was set as the maximum in our quantitative scale, thus, this assay could be 
used to analyze mutant RctB proteins that have ~1% replication competence.  The 
standard deviation for all RctB proteins tested was 0.09 or less across the replicates. 
2.3.5 Matrix-assisted Laser Desorption Time-of-Flight Mass Spectrometry 
(MALDI-TOF MS) analysis  
To probe for RctB domain organization, trypsin proteolysis of full-length RctB 
was performed at room temperature with a trypsin:RctB ratio of 1:500 followed by 
MALDI-TOF MS analysis. At various time points during digestion, 0.5 µL of the sample 
was collected and mixed with 9.5 µL of matrix consisting of a saturated solution of α-
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cyano-4-hydroxycinnamic acid (CHCA) in a 1:3:2 (v/v/v) mixture of formic 
acid/water/isopropanol (FWI). An aliquot of 0.5 µL of this protein-matrix solution was 
spotted onto a MALDI plate precoated with an ultrathin layer of matrix (48,49). The 
sample spots were washed for a few seconds with 2 µL of cold 0.1% aqueous 
trifluoroacetic acid (TFA) solution. MALDI spectra were acquired in linear, delayed 
extraction mode using a Spiral TOF JMS-S3000 (JEOL, Tokyo, Japan). The instrument is 
equipped with a Nd:YLF laser, delivering 10-Hz pulses at 349 nm. Delayed extraction 
time was set at 1 µs and acquisition was performed with a sampling rate of 2 ns. Each 
MALDI spectrum corresponded to an average of 500 scans. Mass calibration was 
performed using a technique of pseudo-internal calibration wherein a few shots on a 
nearby calibrant spot are collected and averaged with the sample shots into a single 
spectrum. The spectra were processed and analyzed using MoverZ (Proteometrics, LLC). 
For characterizing protein degradation in the crystallization drop, one to two 
protein crystals covered in residual mother liquor were removed from a crystallization 
drop, and dissolved in the matrix solution (same as above).  A 0.5 µL aliquot of the 
resulting protein-matrix solution was spotted onto a MALDI plate precoated with an 
ultrathin layer of matrix (48,49).  The sample spots were then washed for a few seconds 
with 2 µL of cold 0.1% aqueous trifluoroacetic acid (TFA) solution. MALDI spectra were 
acquired and processed as detailed above. 
2.3.6 Native mass spectrometry 
RctB proteins samples were diluted to 10–20 µM with 10 mM Tris pH 7.4, 500 
mM NaCl and subsequently buffer-exchanged into the native MS buffer (500 mM 
ammonium acetate, 0.01% Tween-20) using the Zeba microspin desalting columns 
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(Thermo Scientific) with a 40-kDa molecular weight cut-off. The buffer-exchanged 
samples were then further diluted with the native MS buffer into the desired 
concentrations ranging from 0.1 µM to 5 µM. An aliquot (2–3 µL) of the sample was 
loaded into an in-house fabricated gold-coated quartz capillary and sprayed using a static 
nanospray source into the Exactive Plus EMR instrument (Thermo Fisher Scientific). The 
EMR was calibrated using cesium iodide. Typical native MS parameters included spray 
voltage, 0.9–1.5 kV; capillary temperature, 100 °C; S-lens RF level, 200; resolving 
power, 8,750 or 17,500 at m/z of 200 corresponding to 32 or 64 ms analyzer transient 
duration, respectively; AGC target, 5x105; number of microscans, 5; maximum injection 
time, 200 ms; injection flatapole, 8 V; interflatapole, 7 V; bent flatapole, 6 V; ultrahigh 
vacuum pressure, 3–5×10−10 mbar; total number of scans, 100. The in-source 
dissociation (ISD) and high energy collision dissociation (HCD) parameters were varied 
accordingly. RAW files were processed manually using Thermo Xcalibur Qual Browser 
(version 3.0.63). 
2.3.7 Crystallization of RctB 
All aspects of the crystallization of full length and shorter variants of RctB were 
carried out using an automated crystallization and analysis instrument available in house. 
Crystals of RctB domain 1 (1-124) were prepared using the sitting drop vapor diffusion 
method by mixing 0.1, or 0.2, or 0.4 µL of the protein solution (22.4 mg/ml RctB-2-124 
in 20 mM Tris pH 7.4, 50 mM sodium chloride, 5% glycerol, 5 mM 2-mercaptoethanol) 
and 0.2 µL of reservoir solution (0.24 M Sodium malonate pH 7.0, 20% w/v PEG 3350). 
Crystals grew within 7 days. Crystals were flash-frozen in liquid nitrogen without 
additional cryoprotection for X-ray diffraction.  
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Crystals of selenomethionine-substituted RctB domain 1 (1 – 124, L48M) were 
grown by mixing 0.1, or 0.2, or 0.4 µL of the protein solution (20.1 mg/ml RctB-2-124-
L48M in 20 mM Tris pH 7.4, 500 mM sodium chloride, 5% glycerol, 5 mM 2-
mercaptoethanol) and 0.2 µL of reservoir solution (0.1 M Sodium HEPES pH 7.5, 20% 
w/v PEG10000). Crystals grew within 7 days. In preparation of cryogenic X-ray 
diffraction, crystals were transferred sequentially, over a period of 10 min, into a set of 
drops that contained 5%, 10%, 15, and 20% glycerol. 
Crystals of selenomethionine-substituted RctB domains 2-3 (155-483) were 
prepared by mixing 0.1, or 0.2, or 0.4 µL of the protein solution (22.7 mg/ml RctB-155-
483 in 20 mM Tris pH 7.4, 500 mM sodium chloride, 5% glycerol, 5 mM 2-
mercaptoethanol) and 0.2 µL of reservoir solution (0.1 M Bis-Tris propane pH 6.5, 0.2 M 
Magnesium chloride, 2% w/v PEG 8000). Crystals grew 10-14 days. In preparation of 
cryogenic X-ray diffraction, crystals were transferred sequentially into a set of drops that 
contained 5%, 10%, 15, and 20% glycerol over a period of 10 min. 
2.3.8 X-ray data collection 
Diffraction data for the RctB-2-124 crystal was recorded at the X-25 beam line at 
Brookhaven National Laboratory using a wavelength of 0.979 Å. The data extended to 
Bragg spacings of 2.0 Å. RctB-2-124 crystallized in space group P21, with the following 
cell parameters: a = 45.84 Å, b = 52.15 Å, and c = 63.53 Å, α = 900, β = 101.50, γ = 900.  
Matthews analysis indicated that the crystal had two molecules in the asymmetric unit 
(Vm = 2.51 A3/Da). Diffraction data for crystals of RctB-2-124-L48M were measured at 
the Stanford Synchrotron Radiation Lightsource at SLAC National Accelerator 
Laboratory using a wavelength 0.9791 Å. The data extended to Bragg spacings of 2.0 Å. 
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RctB-2-124-L48M crystallized in space group P1, with the following cell parameters a = 
32.45 Å, b = 38.17 Å, and c = 63.04 Å, α = 97.460, β = 91.490, γ = 98.430.  Matthews 
analysis revealed that two molecules in the crystallographic asymmetric unit (Vm = 2.58 
A3/Da). Data for the RctB-155-483 crystal was recorded at the Northeastern 
Collaborative Access Team (NECAT) facility at the Advanced Photon Source at Argonne 
National Laboratory using a wavelength 0.9792 Å.  The data extended to Bragg spacings 
of 2.6 Å. RctB-155-483 crystallized in space group R3, cell dimensions are a = 128.54 Å, 
b = 128.54 Å, and c = 127.8 Å, α = 900, β = 900, γ = 1200. Matthews analysis suggested 
that the two molecules resided in the asymmetric unit (Vm = 2.58 A3/Da). 
2.3.9 Structure determination and refinement 
Diffraction data were processed using HKL2000 software (50). Phenix (51) was 
used to solve the structures of RctB-2-124-L48M and RctB-155-483 using the single 
wavelength anomalous dispersion method and crystals with selenomethionine substituted 
protein. The final model of RctB-2-124-L48M consists of residues 7-122 with a 
crystallographic R factor of 21.46% and Rfree of 25.09%. The final model of RctB-155-
483 consists of residues 182-472 (with a 14-residue gap 242-255) with a crystallographic 
R factor of 24.00% and Rfree of 28.38%.  
The RctB-AA-2-124 structure was solved using molecular replacement (with the 
RctB-2-124-L48M structure as a search model) in Phenix (51). The final model of RctB-
2-124 consists of residues 7-122 with a crystallographic R factor of 24.03% and Rfree of 
28.04%. In all cases, initial models were improved using several rounds of model 
building and refinement as implemented in Phenix (51), Coot (52) and Phenix.refine (51). 
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Structural models were visualized with Coot (52) and PyMol (MacPyMOL: The PyMOL 
Molecular Graphics System, v1.7.0.5 Schrödinger, LLC). 
2.3.10 Crystallographic computing and structural analyses 
Global structural alignments were performed using DALI on-line server (53) and 
PDBefold online-server (54). Structural alignments using particular regions of a structure 
were performed in Pymol (MacPyMOL: The PyMOL Molecular Graphics System, 
v1.7.0.5 Schrödinger, LLC). Other calculations were carried out in the CCP4 (55) and the 
Uppsala Software Factory (56,57) software suites. 
2.4 RESULTS 
2.4.1 RctB folds into a four-domain structure organized around two central 
domains related to plasmid initiators 
Our efforts to crystallize full-length RctB were thwarted by spontaneous 
proteolysis in the crystallization drop. Consequently, we used limited proteolysis and 
mass spectrometry (MS) to identify stable fragments more amenable for structure 
determination by X-ray crystallography. Limited proteolysis of RctB resulted in rapid 
release of a ~14 kDa N-terminal segment (residues 1-124, referred to as domain 1 below) 
and a ~38 kDa segment (residues 155-483, referred to as domains 2-3 below) (Figs. 2.2, 
S 2.1, S 2.2). Although our analysis did not yet identify a stable fragment corresponding 
to the C-terminus (residues 484-658), RctB mutants deleted for these C-terminal residues 
exhibit defects in binding to the inc and rctA 39-mer sequences in oriCII (35,38), 
suggesting that this segment constitutes a fourth domain. Thus, RctB appears to adopt an 




Figure 2.2. Sequence conservation, domain architecture, and structures of the RctB initiator 
protein. A) A BLAST alignment (58) consisting of 99 RctB orthologues was converted to a numerical 
conservation score where equivalence of amino acid at each position was established using a normalized 
BLOSUM62 matrix (59). Conservation score is plotted against the primary sequence (gray lines). Reds 
dots represent positions with greater 90% sequence conservation. B) Domain architecture of RctB as 
deduced from mass spectrometric analysis of proteolytic digestion products. A precise boundary for the 
fourth domain of RctB could not be obtained owing to this region’s sensitivity to limited proteolysis. The 
cleavage sites revealed by our analysis are depicted with scissors. C. The crystal structures of RctB domain 
1 and domains 2-3 are shown in a cartoon representation. The coloring scheme employed corresponds to 
that in figure 2.2B. The dotted line represents one protomer of the RctB dimer. Full-length RctB forms a 
dimer, and the dimerization interface localizes to domain 2. 
 
The structures of both the 14 kDa N-terminal (domain 1) and the 38 kDa middle 
fragments (domains 2-3) were determined using X-ray crystallography (Table S 2.2). 
Two crystal forms of domain 1 (one with the wild-type sequence and native 
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sulfomethionine, and a second with an L48M substitution containing selenomethionine) 
were used to decipher its structure; both forms contain two copies in the asymmetric unit, 
but with different crystal packing arrangements. The four structures of the N-terminal 
domain of RctB (molecules A and B from each of the two crystal forms) were virtually 
identical (RMSD over C-alpha atoms varies from 0.23 to 0.543 Å, Fig. S 2.3). We 
focused our analyses on molecule A of crystal form I (residues 2-124, L48M), as this was 
the best-defined structure. RctB domain 1 consists of an array of four helices packed 
against a four-stranded beta sheet (Fig. 2.2C). Comparative structural analyses using the 
Dali (53) and PDBefold (54) tools revealed that RctB’s domain 1 closest structural 
neighbors are a number of DNA binding proteins, including transcription factors and 
replication initiators. The top hit (1Q1H) was archaeal TFIIE (a component of the core 
transcriptional machinery).  Closer analysis of hits with Z-scores of 5.0 or higher 
revealed a high degree of structural similarity between three alpha helices and two beta-
sheets of RctB domain 1 (residues 42-57, 65-72, 78-91, 94-97, 111-114) and a family of 
winged-helix-turn-helix motif proteins (RMSD from 1.3 to 3.0 Å, Fig. S2.4). No function 
has yet been ascribed to RctB domain 1; however, these comparisons raise the possibility 
(supported by findings shown below) that domain 1 binds to DNA. 
The 38 kDa fragment of RctB (residues 155 – 483) crystallized as a dimer in the 
asymmetric unit; the two RctB monomers are configured in a head-to-head arrangement. 
The dimerization interface of RctB domains 2-3 localizes exclusively to domain 2, and is 
comprised of two seven stranded beta sheets arranged in a domain swapped configuration 
whereby one monomer contributes four of the seven strands to one sheet, and the 
remaining three come from the second monomer; this arrangement is reversed in the 
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second sheet (Fig. 2.2, Fig. S2.5). This configuration represents the most extensive 
protein-protein interface in the crystal (~4300 Å2), and is likely to be functionally 
significant (60). We pursue this question further below. Each 38 kDa monomer is 
composed of two domains - residues 182 to 360 (henceforth domain 2) and residues 361 
to 472 (henceforth domain 3). Superposition analysis revealed a small (~9°) difference 
between the relative orientation of domains 2 and 3 in the two copies present in the dimer 
seen in the asymmetric unit, suggesting flexibility between the two domains (Fig. S2.6).  
Structural comparisons against the PDB (53,54) revealed that the 38 kDa 
fragment of RctB bears significant similarity to several replication initiator proteins from 
plasmid DNA replication systems, including π (2NRA, (61)), RepE (2Z90, (62), 1REP, 
(15)), and RepA (1HKQ, (14)), (Z scores of between 7.7 and 9 using the DALI server). 
Nearly every secondary structure element of π or RepE can be mapped on to a 
corresponding element of RctB domain 2 or 3 (Fig. 2.3, Figs. S2.7, S2.8). For RepA, the 
structure of only one domain of the two is available, and its secondary structure elements 
correspond to RctB domain 2 (Fig. 2.3); the structure of the second domain of RepA is 
not known, but it likely resembles the corresponding domain of RepE based on primary 
sequence considerations (15). However, domains 2 and 3 of RctB also include some 
unique structural elements (Fig. 2.3). Both RepE and RepA crystallized as dimers 
(14,62), with a beta sheet arranged in a domain swapped configuration as in RctB.  
However, unlike in RctB, the interfacial beta sheet for the RepE, and RepA initiators 
contains five strands instead of seven; however, all – RepE, RepA and RctB – are 
arranged as head-to-head dimers. The structures of these plasmid initiators, like that of 
the corresponding RctB fragment, consist of two domains; both have been shown to bind 
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DNA (14,15,61), suggesting that RctB domains 2 and 3 might likewise both bind to DNA 
(as is confirmed below). Additional database searches using the RctB domain 2 and 3 
structures individually revealed similarities with a variety of winged helix turn helix 
DNA binding domains, including the archaeal and eukaryotic replication initiator 
proteins Cdc6 and Orc2 proteins (Figs. S2.9, S2.10). Collectively, these analyses suggest 
that RctB is a four-domain protein with a core region (domains 2 and 3) structurally 
homologous to plasmid initiators, and two unique peripheral domains (domains 1 and 4), 






Figure 2.3. The structures of the central domains of RctB resemble the structures of plasmid 
initiators π, RepE, and RepA. The structure of the central domains (domains 2-3) of RctB was aligned to 
the π (Z-score = 9.0, RMSD = 4.9 Å), RepE (Z-score = 8.4, RMSD = 6.1 Å), and RepA (Z-score = 7.7, 
RMSD = 2.9 Å) plasmid replication initiators. Depicted here is an alignment of secondary structure 
elements extracted from this alignment. Elements shared by each protein are colored in cyan. Elements 
unique to RctB are colored in orange, while elements present in the plasmid initiators, but not in RctB, are 
colored in black. Grey circles represent regions of the various structures that were not modeled. Depiction 
of RepA is limited to the one available domain. A schematic in the bottom right corner shows that RctB 
middle portion (domains 2 and 3) aligns with the entire structure of π, therefore the secondary structure 
alignment is shown only for domains 2-3 of RctB and structures of the plasmid initiators. 
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2.4.2 RctB harbors at least three DNA binding surfaces 
Mutational analyses were used to explore the possibility that the winged helix turn 
helix motifs in RctB domains 1, 2, and 3 all mediate DNA binding. Comparisons against 
close structural homologs bound to DNA were used to predict RctB residues likely to 
contact DNA. Mutations at the selected sites were introduced into full-length RctB, and 
the DNA binding capacity of mutant proteins was subsequently assessed using 
electrophoretic mobility shift assays (EMSA). Additionally, the biological activity of 
mutant proteins was assessed using a transformation assay in which the capacity of RctB 
variants to support oriCII-min-based plasmid replication was determined (35,39). 
Solution properties of mutant RctBs were tested as well; unless otherwise noted, solution 
properties of the mutant proteins determined by size-exclusion chromatography did not 
differ from those of the wild-type protein, indicating that substitutions did not cause 
aggregation or degradation of mutant proteins (Fig. S2.11). Notably, our analyses below 
do not represent a complete census of DNA binding contacts by RctB. 
For RctB domain 1, comparative analyses using five distinct protein-DNA 
complexes (Fig. 2.4A) suggested that Gln 83 on helix αD might be important for DNA 
binding. Additionally, given their 100% conservation in RctB amino acid sequences from 
diverse Vibrio species (Fig. S2.12), we hypothesized that the neighboring positively 
charged residues Arg 84 and Arg 86 might also have roles in DNA binding. To evaluate 
these predictions, we mutated all three positions to alanine, and measured the affinity of 
the resulting triple mutant (RctB Q83A-R84A-R86A, referred to as domain 1 triple 
mutant below) to six probes containing nucleotide sequences derived from oriCII: 1) the 
array of six 12-mers in oriCII-min, 2) a single 12-mer sequence, 3) a single 11-mer 
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sequence from the inc region, 4) the 29-mer sequence (corresponding to the RctB 
promoter), 5) the inc39-mer sequence, and 6) the rctA39-mer sequence (Fig. 2.1). The 
domain 1 triple mutant bound to the 6x12-mer array EMSA probe with an apparent Kd 
(Kdapp) > 23,000x higher than that of wild type RctB (Figs. 2.4, S2.13). Determination of 
precise Kdapp values from EMSAs using other probes was challenging owing to complex 
binding curves; nevertheless, the trend we observed with probe #1 was recapitulated with 
probes #2 and #3 (Figs. S2.14-2.15). However, domain 1 triple mutant binding to the 29-
mer, 39-mer and rctA sequences was similar to that of wild-type RctB (Figs. S2.16-2.18). 
The near wild-type binding of the RctB-Q83A-R84A-R86A mutant to a subset of the 
probes examined supports the idea that its structural integrity is intact. Thus the role of 
domain 1 binding to DNA appears to vary depending upon the target sequence, and 
domain 1 does not appear to play a critical role in binding to most regulatory sequences 
outside of oriCII-min. Consistent with its severe deficiency in binding to the oriCII-min 
probe, RctB domain 1 DNA-binding mutant failed to support oriCII-min-based 
replication (Fig. 2.4). Taken together, these observations strongly suggest that RctB 
domain 1 binds oriCII DNA, and that this function is critical for the capacity of RctB to 
mediate oriCII-based replication.  
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Figure 2.4. RctB has three DNA binding domains.  Structural comparisons predicted the 
presence of at least three distinct DNA binding domains in RctB. To evaluate these predictions, three 
mutant forms of RctB were studied: A) RctB Q83A-R84A-R86A (domain 1), B) RctB K271A-K272A-
S274A (domain 2), and C) RctB R420A-R423A (domain 3). The top of each panel depicts a ribbon 
representation (colored blue) of the predicted DNA binding domain of RctB modeled onto a DNA molecule 
taken from a structural homolog bound to its DNA target. The residues selected for analysis are shown in a 
ball and stick representation (colored orange). 
The middle portion of each panel summarizes, in a sequence alignment format, the structural 
alignment of the DNA binding domains that emerged from database searches. The residues tested in this 
study are shown in orange, and labeled with orange stars. Shown in green are positions implicated in DNA 
binding by other studies (15,61,63-68).  
The lower portion of each panel shows the binding affinity for oriCII-min and performance in the 
transformation assay by wild-type and the mutant RctB proteins.  
 
A similar experimental approach was used to assess candidate DNA-binding 
residues in RctB domains 2 and 3. The structure of RctB domain 2 was compared to 
those of plasmid initiators (RepE and π) in complex with DNA, as well as to a variety of 
winged-helix-turn-helix containing protein-DNA complexes. As such, domain 2 residues 
Lys 271, Lys 272, Ser 274, Arg 278, Asp 279, and Arg 282 were selected for analysis. 
The residues at these positions were absolutely conserved in all RctB sequences 
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examined (Fig. S2.12). Two distinct triple mutant proteins, RctB-K271A-K272A-S274A 
(referred to as the first domain 2 triple-mutant below) and RctB-R278A-D279A-R282A, 
were prepared to test the importance of the substituted residues in RctB binding to oriCII 
and in replication. The first domain 2 triple-mutant (RctB-K271A-K272A-S274A) 
exhibited reduced binding affinity to all 6 oriCII derived DNA probes examined (Figs. 
2.4, S2.13-2.18); e.g., its binding affinity (apparent Kd) for the 6x12-mer array probe was 
reduced by ~1000-fold. A similar trend was observed with the remaining probes tested 
(Fig. S2.14-2.18). Concordant with its markedly defective binding to oriCII DNA 
sequences, the first domain 2 triple-mutant (RctB-K271A-K272A-S274A) was also 
unable to support oriCII-based replication (Fig. 2.4). The RctB-R278A-D279A-R282A 
mutant could not be produced in soluble form and was not analyzed. 
Candidate DNA-binding residues in domain 3 were identified through structural 
alignment of RctB to PhoB bound to its target DNA (PDB entry 2Z33); based on this 
analysis, we anticipated that a number of residues, including Arg 420 and Arg 423, would 
be required for DNA binding, and generated the RctB-R420A-R423A, referred to as 
domain 3 double-mutant. Similar to the domain 1 triple-mutant, domain 3 double-mutant 
bound to three of the six DNA probes tested differently than wild type RctB. The Kdapp of 
RctB R420A-R423A binding to the 6 x12-mer array probe was ~1500-fold lower than 
wild type RctB (Figs. 2.4, S2.13), and similar marked reductions in binding to individual 
12-mer and 11-mer containing probes were observed (Figs. S2.14, S2.15). However, 
domain 3 double-mutant binding to the 29-mer, 39-mer and rctA sequences was similar 
to that of wild-type RctB (Figs. S2.16-2.18). We note that the near wild-type binding of 
the domain 3 double-mutant to a subset of the probes examined supports the idea that its 
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structural integrity is intact. Moreover, in contrast to the domain 1 and domain 2 mutants 
(RctB Q83A-R84A-R86A and RctB-K271A-K272A-S274A, respectively) domain 3 
double-mutant could support oriCII-min-based replication, albeit at reduced efficiency 
compared to wild-type RctB. 
Collectively, these experiments strongly suggest that at least three of the four 
RctB domains are involved in contacting DNA, and, thus, that the protein contains a 
much more extensive DNA binding surface than was previously appreciated (69).  
Moreover, the observation that the R420A-R423A mutation only disrupts binding to a 
subset of oriCII-derived sequences raises the possibility that RctB forms structurally 
distinct complexes on its varied DNA targets within oriCII, and that these complexes rely 
on different RctB domains to contact DNA (a summary of the DNA-binding phenotypes 
of all the mutants appears in table S2.6). However, elucidation of the precise division of 
labor between the three RctB DNA binding domains will require future structural and 
functional analyses.   
2.4.3 RctB forms a head-to-head dimer not compatible with origin binding 
RctB crystallized in a head-to-head dimeric configuration. However, the head-to-
tail array of six 12-mer sites at oriCII implies that the complex on DNA will feature an 
RctB oligomer with a matched configuration. Also, RctB is known to be a dimer in 
solution, but its configuration has not been described (69). To better understand RctB 
oligomer dynamics, we performed mass measurements in solution, examined crystal 
packing for clues on the nature of potentially distinct oligomers (dimers and higher order 
oligomers), and measured the effects of disrupting the dimer seen in the crystal. First, we 
analyzed the oligomeric state of full-length RctB and a panel of single and multi-domain 
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RctB fragments, using native mass spectrometry (MS) (Figs. 2.5A, S2.19; figure S2.20 
shows SEC data and native mass spectrometry data as well). Our findings indicate that 
full-length RctB is a dimer in solution, consistent with previous reports (38,69). In 
addition, only the segments containing the wild-type domains 2-3 form dimers in 
solution, while all others are monomeric under the conditions tested (Figs. 2.5A, S2.19). 
This finding implies that, in solution, the dimer interface is mediated by the core plasmid 
initiator homology domains (domains 2-3) of RctB. 
Second, we examined the packing environments associated with the two crystal 
forms of domain 1 and the single crystal form of domains 2-3 for potential 
physiologically relevant interfaces. Both RctB domain 1 and domains 2-3 crystallized as 
dimers in the asymmetric unit. The surface area buried by the various interfaces made by 
domain 1 in the crystal ranged from 30 to 1340 Å2, values at the low end for a 
physiologically relevant interface (60). Thus, we conclude that the likelihood of 
physiologic relevance for one of the interfaces made by domain 1 in the crystal is low. 
This finding is in concert with results from native MS of wild-type domain 1 (bottom 












Figure 2.5. RctB adopts a 
head-to-head dimeric 
configuration in solution. 
A) Native mass 
spectrometric analysis of the 
oligomeric state of full length 
and truncated constructs of 
RctB, including variants that 
harbored the D314P mutation 
(wild-type: red, mutant: 
black). Spectra for the wild-
type and D314P entities are 
grouped together. To the left 
of each spectrum appears a 
schematic, colored as in 
figure 2.2B, of the 
configuration revealed by the 
analysis. B) The head-to-
head dimer of RctB seen in 
the crystal. The Asp314 
residue on each protomer is 
depicted as a red sphere. 
Residues shown to be 
involved in contacts to DNA 
are depicted in the ball-and-
stick representation and 
colored dark blue.  The two 
monomers of RctB are 
colored in varying shades 
(domain 2: orange, domain 3: 
purple). One of the RctB 
monomers is outlined with a 
dashed line. C) Binding 
affinity for oriCII-min and 
performance in the 
transformation assay for 










In contrast, the non-crystallographic dimer of RctB domains 2-3 buries an 
extremely large amount of surface area (~4300 Å2), a value consistent with physiologic 
relevance (60). To further explore the biological role of the RctB dimer seen in the 
crystal, we substituted a proline residue (D314P) in the beta strand closest to the dimer 
interface to disrupt the dimerization process and produce a monomeric form; such a 
strategy was used with the RepE plasmid initiator (15).  This D314P substitution was 
introduced into three RctB constructs: 1) full-length (residues 1-658), 2) the smallest 
fragment that is active in replication initiation (residues 1-499), and 3) the domains 2-3 
construct (residues 155-483). Native MS analyses of these mutant proteins revealed that 
they were all monomers under the conditions tested (Figs. 2.5A, S2.19). Furthermore, 
DNA binding assays indicated that monomeric RctB-D314P bound to all six probes with 
near wild-type affinity (Kdapp for the binding of the D314P mutant to oricII-min was 
0.003 ± 0.006 nM versus 0.014 ± 0.01 nM for the wild-type) (Fig. 2.5C). This stands in 
contrast to results from the transformation assay where the capacity of the RctB-D314P 
mutant to support replication was reduced (efficiency of 0.11 versus 1 for wild-type) 
(Fig. 2.5C). These findings suggest that the head-to-head dimer of RctB observed in the 
crystal corresponds to the dimer revealed by native MS in solution. Additionally, the 
solution configuration of the RctB dimer implies incompatibility with binding to the 
head-to-tail array of 12-mer binding sites seen in oriCII. It is likely that a substantial 
rearrangement will accompany formation of the RctB – origin DNA complex that 
mediates replication initiation. The incompatibility of RctB head-to-head dimer with the 
head-to-tail array of the 12-mer binding sites is not entirely surprising, since the same is 
true for plasmid initiator systems. Plasmid initiators, which are structurally related to 
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RctB, also exist as head-to-head dimers in solution, and the current model suggests 
monomerization takes place prior to binding the head-to-tail sites on the replication origin 
(62).   
Taken together, our data shows that RctB adopts a head-to-head dimeric 
configuration in solution; this arrangement resembles similarly configured dimers of the 
RepA and RepE plasmid initiators (14,62). Moreover, the dimerization interface is 
localized to RctB domain 2. Notably, our findings do not exclude the possibility that 
other segments of RctB may play significant roles in oligomeric forms of RctB, indeed 
the symmetry mismatch between the two-fold rotational symmetry of the head-to-head 
dimer and the translational symmetry of the RctB binding sites at the origin make this 
very likely. 
2.5 DISCUSSION 
In contrast to the well-studied DnaA-OriC ensemble that operates in all bacteria, 
little is known about molecular mechanisms that mediate replication of secondary 
chromosomes in bacteria with multipartite genomes.  RctB, the conserved initiator of 
chrII replication among the Vibrionaceae, lacks homologs outside of this large family of 
organisms whose genomes are divided between two chromosomes. Although RctB bears 
no significant sequence similarity to other proteins, we demonstrate here that the 
structure of the two central domains of RctB (RctB 2-3) bears significant structural 
similarity to several well-characterized plasmid initiators including RepE (from the F-
plasmid), RepA (from the pPS10 plasmid) and π (from the R6K plasmid). However, 
RctB is considerably larger, and contains at least 2 additional domains.  Three RctB 
domains contain winged helix turn helix DNA binding motifs, all of which were 
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implicated in binding to oriCII, and in the initiator’s capacity to mediate oriCII-based 
replication. In the crystal and in solution, RctB adopts a head-to-head dimeric 
configuration mediated by interactions between residues in domain 2. However, this 
arrangement is not structurally compatible with binding to the head-to-tail array of 12-
mer RctB binding sites in oriCII (Fig. 2.6). Additionally, we found that dimerization-
deficient RctB retained affinity to oriCII, but exhibited a greatly reduced ability to 
support replication.  
 
Figure 2.6. Incompatibility of a head-to-head dimer structure with origin binding. RctB 
middle fragment structure is shown as a ribbon representation. Domains 2 are colored in different shades of 
orange, domains 3 are colored in different shades of purple. The top RctB monomer is shown by dotted 
line. The bottom monomer is modeled to be bound to its site on the origin, according to our findings about 
the residues involved in the DNA binding and structural alignments; the two winged-helix-turn-helix 
domains contact two adjacent major grooves of the DNA, the DNA binding residues are shown as red 
sticks. When one of the monomers is bound to DNA, the DNA binding residues of the second monomer are 
located very far away from the DNA, and they can not interact with the following binding site on the DNA. 
Therefore a head-to-head RctB dimer is incompatible with origin binding not only because of the binding 
site orientation (direct repeats), but also because of the molecule geometry that does not allow the second 
monomer to contact the same DNA molecule. 
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A segment of RctB between domains 3 and 4 has also been proposed to mediate 
RctB dimerization and DNA binding (69). Our data do not support these results. Rather, 
our structural, mutational, and native MS analyses provide strong evidence that DNA 
binding and dimerization are instead dependent upon other regions of RctB. However, we 
cannot exclude the involvement of this or other segments in weak contacts in the 
expected oligomer formed on origin DNA. 
The oligomeric state of plasmid initiators, which like RctB, are dimers in solution, 
is thought to regulate their activity. It has been proposed that plasmid initiator dimers 
dissociate into monomers prior to binding their respective replication origins, whose 
arrangement of binding sites resembles that oriCII (14,15,61). It is tempting to propose 
that formation of the RctB – oriCII replication initiation complex may involve 
dissociation of the RctB dimer into monomers, which then seed formation of a new RctB 
oligomer in the complex on origin DNA; such a complex is also predicted to form on 
plasmid origins (14,15). However, our observation that disruption of the RctB dimer 
diminishes, rather than enhances, biological activity as the above model predicts, and as 
observed with plasmid initiators (70,71) does not, at present, allow us to rule out more 
complicated protein-DNA complexes. Alternate models, such as, for example, where an 
array of RctB dimers, not monomers, bind to origin DNA are possible; however, in such 
models, steric constraints make it unlikely that both members of the head-to-head dimer 
contact DNA. This observation has a precedent with the bacteriophage lambda cII 
protein, where two protein dimers, each with two DNA-binding domains, however, only 
one DNA-binding domain within each dimer binds to the major groove of the DNA 
molecule (72). In addition, match in symmetry between the array of binding sites at the 
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origin and the proteins that will populate these sites requires clarification. The question of 
symmetry between protein configuration and DNA target sites has also been considered 
with the steroid hormone receptors (73-77). Typically, these proteins bind to a pair of 
target sites that exhibit head-to-head or head-to-tail configurations. With rare exception 
(78), the symmetry of the DNA target matches that of the protein (73-77) (i.e. a head-to-
tail array of DNA sites is bound by proteins that are arranged in head-to-tail manner, etc), 
and we anticipate this to be true in the RctB – DNA complex.  Comparisons between 
RctB - DNA complexes and those made by hormone receptors to their target sites are 
limited, though, because RctB binds to an array of six sites and the receptors are limited 
to two sites. Indeed, it is likely that a series of novel contacts, not seen in our head-to-
head dimer structure, will further stabilize the RctB oligomer. A more precise definition 
of the RctB origin DNA complex must await future studies.  
Although similarities between RctB and plasmid initiators were not recognized 
prior to our work, previous studies have commented on similarities between iteron 
plasmid and oriCII-based replication systems (20,21). Identification of the structural 
similarity between RctB and plasmid initiator proteins provides greater understanding of 
parallels between these systems. For example, the origins from chrII and plasmids share a 
number of elements, including directly repeated initiator binding sites. However, close 
examination reveals important differences, for example, the 12 bp length of the RctB 
binding site is considerably shorter than the 19-22 bp length of iterons in plasmid origins. 
Structures of plasmid initiators bound to DNA provide insight on likely interactions 
between RctB and its binding sites on oriCII-min (Fig. 2.7). Notably, these models 
suggest that only one of the three DNA binding domains on RctB can be accommodated 
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on one face of the 12-mer sequence, and make sequence specific contacts in the major 
groove. Thus, it seems likely that some DNA binding sites within RctB recognize 
sequences other than the 12-mer, even in the context of the 6x12 array, since we have 
shown that all three domains contribute to interactions made by RctB with this probe. 
One possibility is that RctB also interacts with the adjacent major groove in the 10 -11 bp 
spacer sequences between the 12-mers, so that the effective target size of RctB is actually 
closer to that found in plasmid origins. If so, then at least one of RctB’s core DNA-
binding domains is likely to lack sequence specificity in binding since the nucleotide 
sequence of the spacer segments is not conserved (39). Given spatial constraints, we 
postulate that domain 1 and domains 2-3 bind to opposite faces of the DNA target, where 
they are presumed to also interact with the major groove (Fig. 2.7). This scheme is 
compatible with the expected head-to-tail arrangement of RctB on the direct repeats in 
oriCII-min, but does not rule out the possibility that there is a division of labor among the 
three RctB DNA binding domains, such that some specialize in contacts to a subset of its 
target sequences, as perhaps evidenced by mutational analysis of domains 1 and 3 (Figs. 
2.4, S2.13-2.18). Future structural analyses of the nature of the oligomeric RctB initiator 
complex on oriCII DNA are required to address these issues. 
The incompatibility of the head-to-head dimeric configuration of RctB with the 
directly repeated 12-mer binding sites implies that a structural reorganization must take 
place prior to formation of the initiator complex on origin DNA. Indeed, this is known to 
be the case for the head-to-head dimeric plasmid initiators, which do not bind to the 
directly repeated binding sites within their cognate origins, unless a chaperone is 
provided to promote disruption of the dimer (16). RctB, however, appears to bind to 
	 45	
oriCII-min without a chaperone (though it is impossible to exclude trace amounts in our 
preparations). Also, disruption of the RctB dimer into monomers does not promote DNA 
binding (Fig. 2.5), as seen with the plasmid initiator RepA (16). This finding implies a 
potential role for the 12-mer RctB binding site itself in the necessary structural 
rearrangement. However, the precise mechanism that mediates rearrangement of the 
dimer remains to be clarified.  It is possible that binding of the head-to-head RctB dimer 
to sites outside of the 6x12mer array in oriCII is important for RctB-mediated regulation 
of initiation or of its own transcription.  
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Figure 2.7. Model for the interaction of RctB with DNA. A) The 12-mer binding site is of 
insufficient length to accommodate the three DNA binding domains of RctB. On the left is a ribbon 
representation of the experimental structure of the π initiator (domains of π are colored in light orange and 
purple) bound to its 22 bp iteron DNA target. Each domain of the π plasmid initiator binds to 
approximately 10 bp of DNA. On the right is shown a schematic of the three DNA binding domains of 
RctB (domain1: cyan, domain 2: orange, domain 3: purple) and its 12-mer binding site (colored in red), 
drawn approximately to scale. We propose that domains of RctB (tentatively domains 1 and 2) will make 
contacts to positions in a 12-mer binding site on either side of the major groove, and that domain 3 
(tentatively) will make contacts to positions in the ‘spacer’ sequence between the 12-mers. 
B) Linear representation of a putative head-to-tail RctB oligomer formed on the array of 12-mer 
sites at oriCIImin.  One of the members of the RctB oligomer is outlined with a dashed line.  
C) Schematic of the putative organization of the RctB oligomer on the 12-mer array in a DNA 
loop configuration to facilitate melting of the A-T-rich region of oriCIImin.  This model is constructed by 
analogy with that proposed for the plasmid initiator (15).   
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Two basic scenarios for the evolution of multi-chromosomal bacteria have been 
put forward (79,80). A single large ancestral chromosome could have split into two 
chromosomes or alternatively, an ancestral strain could have acquired a plasmid, which 
subsequently acquired essential genes. In this context, our discovery that the structure of 
the core of RctB resembles plasmid initiator proteins lends strong support for the plasmid 
acquisition scheme. However, RctB and oriCII also contain features not found in 
plasmids. Notably RctB has two additional domains, one of which is critical for oriCII 
binding and replication.  It seems plausible that these additional domains arose during the 
evolution of the Vibrionaceae, and allow for the more stringent regulatory requirements 
necessary for proper chromosome maintenance. 
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2.9 SUPPLEMENTARY INFORMATION 
 
Supplementary Figures  
 
Figure S2.1. Time-course analysis of limited proteolysis of RctB using mass spectrometry. Trypsin 
digestion of full-length RctB (with 658 residues plus a C-terminal linker and hexa-histidine tag) visualized 
at different time points by (A) SDS-PAGE and (B) MALDI-TOF mass spectrometry (MS). Digestion was 
performed at room temperature with a trypsin:RctB ratio of 1:100 (A) or 1:500 (B). The gel bands in (A) 
were assigned based on the measured masses obtained from MS analysis and labeled based on the peak 
assignments on the MALDI spectra in (B). Measured mass is expressed as the average of calculated masses 
across the charge state distribution. Mass deviation corresponds to the mass difference between the 
measured mass and expected mass derived from the protein sequence. Peaks labeled with an asterisk (*) 




Figure S2.2. Mass spectrometry of proteolysis of RctB-1-499 during crystallization. RctB degradation 
products in the crystallization drop characterized by MALDI-TOF mass spectrometry (MS). The measured 
mass is expressed as the average of calculated masses across the charge state distribution. Mass deviation 
corresponds to the mass difference between the measured mass and expected mass derived from the protein 
sequence. A set of measured masses matches the N-terminal portion of the protein (blue triangles). The 
39.8 kDa mass most likely spans the middle portion of RctB (green triangle). Several masses (38 kDa, 37 
kDa, and marked by **) could not be confidently matched to the amino acid sequence, as several 
boundaries are possible, however, these masses most likely correspond to the central domains of RctB. 




Figure S2.3. Four instances of RctB domain 1 in distinct crystal environments adopt the same 
conformation. The two molecules from the RctB-2-124 crystal are colored in shades of yellow, while 
those from RctB-2-124-L48M crystal are colored in shades of green. Structural alignment of the four 
molecules revealed an RSMD 0.23-0.543 (C-alpha atoms). The structures of the four molecules are 




Figure S2.4. Structural alignment of domain 1 with various DNA binding proteins using DALI (53) 
and PDBefold (54). RctB domain 1 is depicted as a red ribbon. The structurally similar proteins (helix-
turn-helix and winged-helix proteins, a majority of which are DNA-binding proteins) are plotted as grey 





Figure S2.5. Domains 2-3 of RctB form a domain-swapped dimer. The two monomers of RctB domains 
2-3 are shown in orange and green. One of the monomers is shown with a dotted line. Circled in red is the 




Figure S2.6. The two monomers in the head-to-head dimer of RctB (domains 2-3) exhibit slightly 
different conformations. RctB-155-483 (domains 2-3) crystallized with two molecules in the asymmetric 
unit. Here, we show that they adopt slightly different conformations. Superposition of on domain 2 reveals 
that relative positions of domain 3 is rotated by ~9 degrees. This variability in the observed conformations 





Figure S2.7. Structural alignment of RctB domains 2-3 and plasmid initiator π. A. A molecular 
representation of the alignment of RctB domains 2-3 (domain 2 is shown in orange, domain 3 is shown in 
purple) and initiator π crystallized with DNA (shown in grey). The DNA-binding helices in RctB are shown 
in brighter colors (yellow in domain 2 and magenta in domain 3), the DNA-binding helices in RctB align 
with DNA-binding helixes in π. B. Schematic comparison of RctB and π; the entire π molecule aligns with 




Figure S2.8. RctB alignment with plasmid initiators. The structure of the central domains (domains 2-3) 
of RctB was aligned to the π (Z-score = 9.0, RMSD = 4.9 Å), RepE (Z-score = 8.4, RMSD = 6.1 Å), and 
RepA (Z-score = 7.7, RMSD = 2.9 Å) plasmid replication initiators. Depicted here is a sequence alignment 
that is based on a structural alignment. Elements shared by each protein are colored in cyan. Elements 
unique to RctB are colored in orange, while elements present in the plasmid initiators, but not in RctB, are 
colored in black. Black circles represent regions of the various structures that were not modeled. Depiction 
of RepA is limited to the one available domain. Amino acid conservation was established using a 
normalized BLOSUM62 matrix (59). Amino acids in the primary sequence are colored from white (<40% 




Figure S2.9. Structural alignment of RctB domain 2 with various DNA binding proteins using DALI 
(53) and PDBefold (54). RctB domain 2 is depicted as a red ribbon. The hits from the Dali and PDBefold 
searches are plotted as thin grey ribbons. RctB domain 2 shows structural similarity to several helix-turn-
helix and winged-helix proteins, a majority of which are DNA-binding proteins. The DNA molecule from 






Figure S2.10. Structural alignment of RctB domain 3 with various DNA binding proteins using DALI 
(53) and PDBefold (54). RctB domain 3 is depicted as a red ribbon. The hits from the Dali and PDBefold 
searches are plotted as thin grey ribbons. Domain 3 shows structural similarity to several helix-turn-helix 
and winged-helix proteins, a majority of which are DNA-binding proteins. The DNA molecule from one of 




Figure S2.11. Wild-type and DNA binding mutants of RctB exhibit similar solution properties. A) 
Size-exclusion profiles for Ni-NTA purified RctB WT and RctB mutants. The pooled peak protein fractions 
are shaded in light blue. B) Pooled fractions from panel A were concentrated to 1 mg/ml and reanalyzed by 
size-exclusion chromatography. In all cases, wild-type and mutant RctB proteins elute as a single peak with 





Figure S2.12. Sequence conservation and secondary structure of domains 1, 2, and 3 of RctB. A 
BLAST alignment (58) consisting of 99 RctB orthologs was converted to a numerical conservation score 
where equivalence of amino acids at each position was established using a normalized BLOSUM62 matrix 
(59). Amino acids in the primary sequence are colored from white (< 40% conservation) to dark green 
(%100 conservation). The secondary structure of RctB domains 1, 2, and 3 – from separate structure 
determinations – is plotted against the primary sequence. Grey circles represent positions in the 






Figure S2.13. Electrophoretic mobility shift assays of wild-type and mutant RctB proteins with a 
probe containing the array of six 12-mer sites from oricIImin. The protein (wild-type or mutant) is 
indicated for each panel (A-E). In all cases, the EMSA gel appears on the left, and a fit of the data to a 
binding curve appears on the right. The protein concentration for each gel are as follows: lane 1: no protein, 
lane 2: 24 fM, lane 3: 98 fM, lane 4: 390 fM, lane 5: 1.6 pM, lane 6: 6.3 pM, lane 7: 25 pM, lane 8: 100 
pM, lane 9: 400 pM, lane 10: 1.6 nM, lane 11: 6.4 nM, lane 12: 25 nM, lane 13: 102 nM, lane 14: 410 nM, 
lane 15: 1.6 mM. The red arrows indicate lanes where the fraction of bound DNA brackets the point of half 
occupancy. The RctB-Q83A-R84A-R86A (B), RctB-K271A-K272A-S274A (C) and RctB-R420A-R423A 
(D) mutants demonstrate reduced binding to the array of six 12-mer sites compared to wild type RctB (A) 
and RctB-D314P (E). By default the following equation was used to fit the data (F = A*x/(Kdapp+x) + B, 
where F – fraction bound, x – protein concentration, and Kdapp is an apparent dissociation constant; in 
experiments where the total DNA concentration (0.1 nM) is comparable to the Kdapp, the following 
quadratic equation was used: F = A*(((Prottot + DNAtot +Kdapp) – ((((Prottot + DNAtot +Kdapp)^2) – 4* 
Prottot* DNAtot)^0.5))/(2* DNAtot)) + B, where Prottot is total protein concentration, DNAtot is total DNA 
concentration (and it is equal to 0.1 nM), Kdapp is an apparent dissociation constant. Error bars represent 





Figure S2.14. Electrophoretic mobility shift assays of wild-type and mutant RctB proteins with a 
probe containing a single 12-mer site. The protein concentration values for each gel are identical to those 
in figure S2.13.  For the experiments in figures S2.12 to S2.16, dissociation constants could not be 
extracted from these experiments due to complex binding interactions. To enable a meaningful comparison 
between gels, we selected lanes in the gel where DNA occupancy was 0.15 (green arrow) and 0.5 (red 
arrow) as handles for comparison. By this measure, we observe an occupancy of 0.15 at 6.3 picomolar 
concentration for wild type RctB (panel A), which reaches 0.5 at 25 nanomolar protein. By contrast, the 
pattern of these two occupancies exhibited by the RctB-Q83A-R84A-R86A (B), RctB-K271A-K272A-
S274A (C) and RctB-R420A-R423A (D) mutants differ markedly and we conclude that the above mutants 
are defective in DNA binding. For RctB-D314P (E), the overall pattern of binding was only slightly altered 
in comparison to wild-type, and we conclude that the monomeric RctB-D314P mutant binds DNA similar 





Figure S2.15. Electrophoretic mobility shift assays of wild-type and mutant RctB proteins with a 
probe containing a single 11-mer site. The protein concentration values for each gel are identical to those 
in figure S13. For these experiments apparent binding constants could not be extracted due to complex 
binding interactions. To enable a meaningful comparison between gels, we selected lanes in the gel where 
DNA occupancy was 0.15 (green arrow) or 0.5 (red arrow) as handles for comparison. By this measure, we 
observe an occupancy of 0.15 at 6.3 picomolar concentration for wild type RctB (panel A), which reaches 
0.5 at 6.4 nanomolar protein. By contrast, the pattern of these two occupancies exhibited by the RctB-
Q83A-R84A-R86A (B), RctB-K271A-K272A-S274A (C) and RctB-R420A-R423A (D) mutants differ 
markedly, thus, we conclude that the above mutants are defective in DNA binding. For RctB-D314P (E), 
the overall pattern of binding was only slightly altered in comparison to wild-type, and we conclude that 
the monomeric RctB-D314P mutant binds DNA similar to wild type.   
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Figure S2.16. Electrophoretic mobility shift assays of wild-type and mutant RctB proteins with a 
probe containing a single 29-mer site. The protein concentration values for each gel are identical to those 
in figure S2.13. For these experiments apparent binding constants could not be extracted due to complex 
binding interactions. To enable a meaningful comparison between gels, we selected lanes in the gel where 
DNA occupancy was 0.15 (green arrow) and 0.5 (red arrow) as handles for comparison. By this measure, 
we observe an occupancy of 0.15 at 1.6 nanomolar concentration for wild type RctB (panel A), which 
reaches 0.5 at 25 nanomolar protein. We conclude that in these experiments wild type RctB (panel A), 
RctB-Q83A-R84A-R86A (B), RctB-R420A-R423A (D) and RctB-D314P (E) share similar DNA binding 
patterns, but binding by RctB-K271A-K272A-S274A (C) was reduced.  
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Figure S2.17. Electrophoretic mobility shift assays of wild-type and mutant RctB proteins with a 
probe containing a single 39-mer site. The protein concentration values for each gel are identical to those 
in figure S2.13. For these experiments apparent binding constants could not be extracted due to complex 
binding interactions. To enable a meaningful comparison between gels, we selected lanes in the gel where 
DNA occupancy was 0.15 (green arrow) and 0.5 (red arrow) as handles for comparison. By this measure, 
we observe an occupancy of 0.15 at 1.6 nanomolar concentration for wild type RctB (panel A), which 
reaches 0.5 at 25 nanomolar protein. We conclude that in these experiments wild type RctB (panel A), 
RctB-Q83A-R84A-R86A (B), RctB-R420A-R423A (D) and RctB-D314P (E) share similar DNA binding 




Figure S2.18. Electrophoretic mobility shift assays of wild-type and mutant RctB proteins with a 
probe containing a single rctA39-mer site. The protein concentration values for each gel are identical to 
those in figure S2.13. For these experiments apparent binding constants could not be extracted due to 
complex binding interactions. To enable a meaningful comparison between gels, we selected lanes in the 
gel where DNA occupancy was 0.15 (green arrow) and 0.5 (red arrow) as handles for comparison. By this 
measure, we observe an occupancy of 0.15 at 6.4 nanomolar concentration for wild type RctB (panel A), 
which reaches 0.5 at 102 nanomolar protein. We conclude that in these experiments wild type RctB (panel 
A), RctB-Q83A-R84A-R86A (B), RctB-R420A-R423A (D) and RctB-D314P (E) share similar DNA 





Figure S2.19. Assembly states of the wildtype and mutant versions of RctB as characterized by native 
MS. The wild-type RctB and all wild-type segments containing domain 2 are dimeric. In contrast, mutant 
versions harboring a single residue substitution in the dimerization interface of domain 2 (D314P) are 
monomeric. The assembly states observed for each sample did not change across the concentration range 
studied. The measured mass of the dominant peak series is shown as the average of all the mass values 
obtained from the charge state distribution (n≥4). The mass accuracy is indicated in parenthesis. 
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Figure S2.20. Size 
exclusion profiles of 
various RctB 
constructs (wild type 
and the D314P 
mutation) and native 
mass spectrometry 
data for RctB-D314P. 
RctB-155-483 and RctB-
155-483-D314P elute 
from SEC as a dimer and 
monomer, respectively 
(A), RctB-1-499 and 
RctB-1-499-D314P elute 
from SEC as a dimer and 
monomer, respectively 
(B); however full-length 
RctB and full length 
RctB-D314P elute at 
essentially the same 
position on SEC; this is 
unexpected as the wild-
type is a dimer and the 
D314P mutant is a 
monomer. (C). Three 
different preparations of 
RctB-D314P full-length 
(from three different 
growths) were examined 
by native mass 
spectrometry, and all of 
them were found to be 
predominantly 
monomers (D, E). 
Native mass 
spectrometry reports on 
the mass, and is, 
therefore, a true measure 
of the oligomerization 
state. We do not know 
why the full-length 
wildtype and monomer 
mutant of RctB share the 
same elution profile on 
SEC. We suspect that 
non-specific interactions 
with the chromatography 
beads, or the overall shape differs between wild-type and mutant. These factors could explain the 





Supplementary table 2.1. Sequences of the various RctB binding sites. The adenine 
residues that require methylation are shown in bold and are enlarged. 
 
Binding site name Sequence 
12-mer ATGATCATGCTT 
11-mer ATGATCAAGAG 






Supplementary table 2.2. Data collection, phasing and refinement statistics for SAD 
(SeMet) structures and the structure obtained with molecular replacement 







Data collection        
Space group   P 1  P 21 R 3  
Cell dimensions          
    a, b, c (Å)   32.45, 38.17, 63.04  45.837, 52.15, 63.533 128.54, 128.54, 127.8  
    a, b, g  (°)   97.46, 91.49, 98.43  90, 101.537, 90 90, 90, 120  
        
Wavelength   0.9791 (peak)  0.979 0.9792 (peak)  
Resolution (Å) 
 
  2.0 (CC1/2  = 0.712)   2.0 (CC1/2  = 0.878) 2.6 (CC1/2 = 0.506)  
Highest resolution shell 
 
  2.03 – 2.00  2.03-2.00 2.64 – 2.60  
Rsym all data (in highest 
resolution shell) 
 
  0.049 (0.496)  0.057 (0.282) 0.053 (0.828)  
<I / sigI> all data (in 
highest resolution shell) 
 
  26.42 (2.44)  17.05 (2.42) 21.7 (0.88)  
Completeness (%) all 
data (in highest 
resolution shell) 
 
  94.3 (96.9)   84.3 (64.6) 99.4 (99.0)  
Average redundancy all 
data (in highest 
resolution shell) 
  2.0 (2.0)   1.6 (1.4) 2.9 (2.7)  
        
Refinement        
Resolution (Å)   2.0  2.0 2.6   
No. reflections   18162  15588 23743  
Rwork / Rfree   0.214/0.247  0.227/0.266 0.235/0.277   
No. atoms        
    Protein   1846  1846 4578  
    Water   152  64 31  
            
B-factors        
    Protein   43.57  49.48 91.05  
    Water   47.31  46.54 63.57  
            
R.m.s deviations        
    Bond lengths (Å)   0.003  0.006 0.002  
    Bond angles (°)   0.58  0.76 0.546  
Ramachandran plot 
statistics (MolProbity) 
       
Ramachandran favored   99.56%  98.68% 96.7%  
Outliers   0%  0% 0%  
PDB code   5UBD  5UBE 5UBF  
SBGrid DataBank ID    10.15785/SBGRID/413  10.15785/SBGRID/412 10.15785/SBGRID/414  
        
 
By default the resolution was determined using CC0.5 > 0.5 criteria. In case of RctB-AA2-124-L48M and RctB-AA2-
124 at the chosen resolution limit CC0.5 is much greater than 0.5, however, the incompleteness of data beyond the 
chosen resolution due to the detector position had to be taken into account as well. For RctB-AA2-124 completeness in 
highest resolution shell is 64.6 %, and completeness goes above 90% in 2.44 - 2.37 shell. For RctB-AA2-124-L48M 
completeness in highest resolution shell is above 90%. In the RctB-155-483 structure, density for residues 242-255 is 
missing and density for residues 450-457 is defined poorly. The Ramachandran plot for these regions should be 




Supplementary table 2.3. Plasmids. 
Plasmid name Vector 
insert 















































































































































































































Supplementary table 2.4. Primers. 
 

















Q83A-R84A-R86A-forward       CAACAGCTACCGCTGCTGCCAAGGCCGCCTGGATGGCTGC
ACGCG 































Supplementary table 2.5. EMSA probes. 
 













































Supplementary table 2.6. Summary of the DNA-binding phenotypes for the mutants 
discussed in the study. 
 
Mutant Binding site 
12x6 12-mer 11-mer 39-mer 29-mer 
(PrctB) 
rctA39mer 



























































































CHAPTER 3 – RCTB – ORICII INTERACTIONS 
3.1 ABSTRACT 
In the previous chapter, we reported the first structure of the secondary 
chromosomal initiator protein. Based on the RctB structure a model of a complete 
macromolecular assembly that RctB forms on the origin DNA was developed and 
discussed in the previous chapter. However, there are unresolved questions, such as what 
is the structure of the fourth domain of RctB and what role it plays in the complex 
assembly and the regulation of RctB function. In this chapter, we discuss the x-ray 
structure of the fourth domain of RctB and the attempts to explain the functions of the 
domain four. Revealing of the function of the C-terminal domain of RctB would allow 
for detailed understanding of various RctB – OriCII interactions. 
3.2 INTRODUCTION 
Despite a lot of effort to elucidate the process of bacterial DNA replication 
initiation, the mechanism of this process at the molecular level remains largely unclear. 
Bacteria possess several types of DNA molecules: such as the primary chromosome, 
plasmids, and in minority of cases secondary chromosome(s). The studies of the 
Escherichia coli’s chromosomal system provided key insights into the mechanism of 
DNA replication initiation. The key players in the process of DNA replication initiation 
are: the specific DNA fragment, called origin of DNA replication (OriC in E. coli 
chromosome), and the initiator protein (DnaA in E. coli chromosomal system). Structures 
of the initiator proteins for the primary bacterial chromosome (DnaA) and a number of 
plasmid initiators (Rep proteins) were solved. There is an abundance of biochemical data 
was available for these two systems: the primary chromosome and the plasmid replication 
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systems. The origin of replication of the secondary chromosome in Vibrio cholerae 
(called OriCII) was studied in detail (39). However, the structure of the initiator protein 
for the secondary bacterial chromosome was not available until a recent study was 
published. The study reported the structures of the three main domains of RctB, the 
initiator protein for the secondary chromosome in V. cholerae (81).  
RctB protein is unique in its amino acid sequence; however the RctB structure 
demonstrated that the core RctB fragment (domains 2-3) shares high degree of structural 
similarity with plasmid replication initiators. The RctB structure provided insights into 
the mode of RctB-DNA interactions and allowed for the development of a hypothesis 
regarding the structure of the RctB-OriCII complex. However, the hypothesis about the 
structure that RctB forms on the replication origin still has some details that require better 
understanding. The two important unresolved questions are: whether RctB monomerizes 
prior to binding to the OriCII and the function of the C-terminal domain of RctB. It was 
reported previously that the C-terminal fragment of RctB is expected to be involved in 
binding of the regulatory RctB binding sites (35,37). On the other hand comparisons 
between the binding pattern of the full-length RctB and the truncated RctB construct that 
is missing the C-terminal fragment (RctB-1-499), suggest that the C-terminal fragment of 
RctB plays a role in protein-protein interactions resulting in cooperativity in DNA 
binding (39). It is important to understand the complex role of the C-terminal fragment of 
RctB to have a complete understanding of the replication initiation machinery in the 
secondary bacterial chromosome. 
We demonstrated that the monomeric RctB-D314P has higher affinity to a probe 
with six binding sites from the OriCII than the wild-type RctB, which suggests that there 
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is an additional event that should take place before the wild-type RctB can bind the 
origin, presumably the monomerization step. We also demonstrated that all the 
intermediate complexes that RctB wild-type and RctB-D314P form on the DNA 
molecules with three or six binding sites have the same exact electrophoretic mobility 
when they are ran on the same gel. These results suggest that the same intermediate 
species are being formed regardless of the original oligomeric state of RctB. 
Our native mass-spectrometry data suggest that domain four of RctB is involved 
in protein-protein interactions, which agrees with our SAXS data and EMSA data. In 
order to investigate the function of domain four in detail, the X-ray structure of the 
domain four of RctB was determined. Based on the crystal structure a series of mutants 
was designed for the future analysis of the function of the C-terminal domain of RctB.  
3.3 MATERIALS AND METHODS 
3.3.1 Plasmids 
The wild-type RctB expression construct has been described previously (35). 
Other RctB expression constructs were described (81). Plasmid for the expression of 
RctB domain 4 (528-658) was generated using conventional PCR-based cloning. 
Plasmids for the expression of RctB mutants were cloned using Quick Change XL II kit 
(Agilent) (Supplementary table 2). 
Plasmids containing the EMSA probes, corresponding to the 12x3 and 12x6 
binding sites were generated by subcloning the relevant dsDNA (Supplementary table 4) 
into the pUC18 vector. 
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A complete list of plasmids, primers, and EMSA probes appears in supplementary 
tables 2, 3, and 4 respectively. The sequence of the insert in each plasmid was verified by 
DNA sequencing (Genewiz).   
3.3.2 Protein biochemistry 
Proteins in this study were produced using standard methods for preparing 
recombinant proteins in bacteria (44). Expression plasmids for full length (35) and 
designed variants ((81), supplementary table 2) included C-terminal hexahistidine affinity 
tags; the full-length RctB constructs (wild type and the mutants), as well as the RctB-1-
499 constructs, contained an additional alanine in position 2 following the first 
methionine, and additional leucine and glutamic acid residues at the C-terminus 
preceding the hexahistidine affinity tag; RctB-528-658 construct contained the 
hexahistidine affinity tag only. All the expression plasmids were grown in E. coli BL21. 
Small-scale growths were performed in LB media supplemented with 50 µg/mL 
kanamycin. Cultures were started by addition of an overnight ‘starter’ culture prepared 
from a fresh transformation at a 5% volume ratio of starter to culture volume. Cells were 
cultured at 37°C until their density reached at OD600 ≈ 0.6-0.7, the culture was cooled to 
approximately 20°C, and protein expression was induced by addition of 1 mM IPTG to 
the culture medium. Protein expression was allowed to continue at 16°C for 14-18 hours. 
Cells were then harvested by centrifugation and resuspended in buffer A (500 mM NaCl, 
50 mM sodium phosphate (pH 8.0), 5% glycerol) at a ratio of 5 ml of buffer A per gram 
of cells. Large scale growths were carried out in a fermenter as above, except that 
SuperBroth (12 g/L tryptone, 24 g/L yeast extract, 2.3 g/L KH2PO4, 12.5 g/L K2HPO4, 
3.2% glycerol), supplemented with 1 mM MgCl2, and 0.1 mM CaCl2 was used in place of 
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LB, 100% oxygen was bubbled through the media at 0.5 – 1 L/min, and the agitation rate 
was set to 450 RPM. The culture was grown at 37°C until its density reached OD600 ≈ 2. 
Protein expression was induced by addition of 1 mM IPTG to the media. Protein 
expression was allowed to proceed for 14-18 hours at 27°C. RctB-528-658 protein 
substituted with selenomethionine was prepared as described (45,46). 
RctB-528-658 proteins (native and selenomethionine-substituted) that were used 
for crystallization were purified using two chromatography steps. The proteins were 
initially purified by thawing frozen biomass cells expressing the appropriate construct 
into Ni buffer A (500 mM NaCl, 50 mM potassium phosphate, pH 8.0) such that a three-
fold dilution was achieved. Cell lysis was achieved by sonication. The soluble fraction 
was then isolated by centrifugation and incubated with nickel-nitrilotriacetic acid (Ni-
NTA) agarose (QIAGEN) for 40 min at 4°C.  Then Ni-NTA agarose beads were washed 
with a set of buffer solutions with increasing imidazole concentration containing up to 50 
mM imidazole; proteins were then eluted by washing with 500 mM imidazole. The 
resulting Ni-NTA purified protein was concentrated, and applied to a size-exclusion 
column (Superdex 200 beads, GE healthcare). Chromatography was carried out in SEC 
buffer: 150 mM NaCl, 20 mM Tris pH 7.4, 5% glycerol, 5 mM beta-mercaptoethanol. 
Fractions containing pure protein were concentrated, and either were used fresh or were 
flash-frozen in liquid nitrogen, and stored until use. The yield was approximately 10 mg 
per liter of culture. 
RctB proteins used for electromobility shift assays (EMSAs) were expressed and 
purified as described above, except that after the Ni-NTA purification proteins were 
directly dialyzed in the following buffer: 500 mM NaCl, 10 mM Tris pH 7.4, 5% 
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glycerol, 5 mM beta-mercaptoethanol. After dialysis proteins were concentrated and 
flash-frozen in liquid nitrogen. 
3.3.3 Limited proteolysis of the C-terminal region of RctB 
The limited proteolysis reactions were conducted in cleavage buffer: 20 mM 
HEPES, pH 7.5, 50 mM KCl, 10 mM MgSO4. The following proteases were used: 
proteinase K, subtilisin, chymotrypsin, elastase. The cleavage reactions were conducted 
on ice using 1:100 and 1:1000 ratios of protease to protein, and at different time points a 
sample of the reaction was mixed with the loading dye (4x SDS sample buffer with 10 
mM EDTA and 10 mM PMSF) and flash-frozen in liquid nitrogen. The products were 
analyzed using 15% SDS-PAGE gels. 
3.3.4 Secondary structure prediction for the C-terminal region of RctB 
The secondary structure prediction for the C-terminal region of RctB was 
obtained using Jpred and Psipred on-line servers. 
3.3.5 Electrophoretic mobility shift assay 
The short EMSA probes that were non-methylated were obtained by annealing 
single-stranded oligos purchased from IDT. However, the methylated probes 
(methylation at the N6 position of the adenine residues in the sequence GATC is required 
for RctB binding to the “12-mer” sites (39)), it was necessary to produce EMSA probes 
by excising them from methylated plasmid DNA. Probe fragments were cloned into the 
pUC18 vector and the constructs were prepped from Dam(+) E. coli. The constructs were 
then digested with EcoRV and treated with CIP (NEB) for 2 hours at 37 0C. The digests 
were separated on 3% agarose gels and the probes were excised and extracted from the 
gel. The DNA was then purified using Illustra MicroSpin G-50 Columns (GE) and the 
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concentration was quantitated with a NanoDrop (ThermoFisher Scientific). The probe 
ends were then labeled with T4 PNK (NEB) and a slight excess of gamma P32 ATP. The 
probes were separated from the nucleotide using  Illustra MicroSpin G-50 Columns (GE).  
Binding reactions were conducted in 20 µL of 1x EMSA reaction buffer: 20mM 
TrisCl pH 8.0, 1mM EDTA,150mM NaCl, 1mM MgCl2, 5% glycerol, 100 µg/mL BSA, 
10 µg/mL poly (dI-dC). Radiolabeled probes were added to a final concentration of 0.2 
nM. The reactions were incubated for 10 minutes at room temperature. Reactions were 
then loaded onto 6% DNA retardation gels and run in 0.5% TBE buffer. The gels were 
then dried onto filter paper and then exposed to a Phosphor Screen and imaged with 
Typhoon FLA-9500 imager. Band intensities were quantified using Image Studio™ Lite 
software (LI-COR, Inc). The data was fit to appropriate binding equations using 
KaleidaGraph 4.5. 
3.3.6 Crystallization the C-terminal domain of RctB 
The crystallization of the C-terminal domain of RctB was carried out using an 
automated crystallization and analysis instrument available in house. Native crystals of 
RctB domain 4 (528-658) were prepared using the sitting drop vapor diffusion method by 
mixing 0.1, or 0.2, or 0.4 µL of the protein solution (23.4 mg/ml RctB-528-658 in 20 mM 
Tris pH 7.4, 150 mM sodium chloride, 5% glycerol, 5 mM 2-mercaptoethanol) and 0.2 
µL of reservoir solution (0.2 M Ammonium acetate, 0.1 M TRIS-HCl pH 8.5, 15% 
Isopropanol). Crystals grew within 7 days. In preparation of cryogenic X-ray diffraction, 
crystals were transferred sequentially, over a period of 10 min, into two drops that 
contained 5% and 20% glycerol (the original protein holding solution plus 5 or 20% 
glycerol). 
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Crystals of selenomethionine-substituted RctB domain 4 (528-658) were prepared 
using the sitting drop vapor diffusion method by mixing 0.1, or 0.2, or 0.4 µL of the 
protein solution (23.3 mg/ml RctB-528-658 in 20 mM Tris pH 7.4, 150 mM sodium 
chloride, 5% glycerol, 5 mM 2-mercaptoethanol) and 0.2 µL of reservoir solution (0.1 M 
Sodium HEPES pH 7.5, 0.15 M magnesium chloride, 19% w/v PEG400). In preparation 
of cryogenic X-ray diffraction, crystals were transferred sequentially, over a period of 10 
min, into two drops that contained 5% and 20% glycerol (the original protein holding 
solution plus 5 or 20% glycerol). 
3.3.7 X-ray data collection 
Diffraction data for the RctB-528-658 native crystal were recorded at the Stanford 
Synchrotron Radiation Lightsource at SLAC National Accelerator Laboratory using a 
wavelength 1.195 Å. The data extended to Bragg spacings of 2.0 Å. Native RctB-528-
658 crystallized in space group P 1 21 1 (P 21), cell dimensions are a = 43.58 Å, b = 64.24 
Å, and c = 47.42 Å, α = 900, β = 90.8160, γ = 900. According to Matthews analysis the 
crystal contains two molecules in the crystallographic asymmetric unit (Vm = 2.11 
A3/Da).  
Diffraction data for the RctB-528-658 selenomethionine-substituted crystal were 
recorded at the Stanford Synchrotron Radiation Lightsource at SLAC National 
Accelerator Laboratory using a wavelength 0.9791 Å. The data extended to Bragg 
spacings of 1.5 Å. Native RctB-528-658 crystallized in space group P31 1 2, cell 
dimensions are a = 46.77 Å, b = 46.77 Å, and c = 118.84 Å, α = 900, β = 900, γ = 1200. 
According to Matthews analysis the crystal contains one molecule in the asymmetric unit 
(Vm = 2.4 A3/Da).  
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3.3.8 Structure determination and refinement 
Diffraction data were processed using HKL2000 software (50). Phenix (51) was 
used to solve the structure of selenomethionine-substituted RctB domain 4 (528-658) 
using the single wavelength anomalous dispersion method and crystals with 
selenomethionine substituted protein. The final model of RctB-528-658 
(selenomethionine-substituted protein crystals) consists of residues 528-655 with a 
crystallographic R factor of 19.8% and Rfree of 22.0%.  
The RctB-528-658 (native protein crystals) structure was solved using molecular 
replacement (with the RctB-528-658 (obtained using selenomethionine-substituted 
protein crystals) structure as a search model) in Phenix (51). The final model of RctB-
528-658 (native protein crystals) consists of residues 528-655 with a crystallographic R 
factor of 18.1% and Rfree of 22.0%. The initial model was improved using several 
rounds of refinement as implemented in Coot (52) and Phenix.refine (51). Structural 
models were visualized with Coot (52) and PyMol (MacPyMOL: The PyMOL Molecular 
Graphics System, v1.7.0.5 Schrödinger, LLC).  
3.3.9 Crystallographic computing and structural analyses 
Global structural alignments were performed using DALI on-line server (53). 
Other calculations were carried out in the CCP4 (55). 
3.3.10 SAXS data analysis 
SAXS data analysis was performed using ATSAS software (82). Primus program 
was used for Guinier analysis. Gnom program was used for evaluation of the particle 
distance distribution function p(r). DAMMIF program was used to generate molecular 
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envelopes (83). CORAL program was used to fit the available domain X-ray structures 
into the scattering pattern of the complete particle (82). 
3.3.11 Native mass spectrometry 
RctB proteins samples were diluted to 10–20 µM with 10 mM Tris pH 7.4, 500 
mM NaCl and subsequently buffer-exchanged into the native MS buffer (500 mM 
ammonium acetate, 0.01% Tween-20) using the Zeba microspin desalting columns 
(Thermo Scientific) with a 40-kDa molecular weight cut-off. The buffer-exchanged 
samples were then further diluted and mixed with DNA probes in order to reach final 
solution containing: 3 or 4 µM protein, 1 µM DNA, 250 mM sodium chloride, 0.01% 
Tween-20, 1mM magnesium chloride. 
An aliquot (2–3 µL) of the sample was loaded into an in-house fabricated gold-
coated quartz capillary and sprayed using a static nanospray source into the Exactive Plus 
EMR instrument (Thermo Fisher Scientific). The data collection parameters and the data 
processing software used as described previously (81). 
3.4 RESULTS 
3.4.1 RCTB MONOMERIZATION  
There are two proposed possible models for the complex formation on the OriCII. 
According to the first model, the RctB dimer monomerizes and the resulting monomers 
assemble a complex with six RctB molecules bound in a head-to-tail manner to the six 
binding sites on the OriCII. The other model suggests that the RctB dimer stays intact 
and the dimers form the final assembly on the replication origin, such that each dimer 
binds to the 12-mer site only with one of its RctB molecules forming the dimer, while the 
other molecule does not contact the DNA. It is important to determine which of these two 
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possible models is the correct one in order to obtain a deeper understanding of the RctB-
OriCII initiation system. 
One of the obstacles that complicated the analysis of the RctB-OriCIImin 
complexes was that in prior EMSA analysis, the DNA probes always contained a vast 
excess of DNA on either side of the binding sites; this could have been a reason why 
RctB demonstrated non-standard binding behavior, and it was not clear how many RctB 
molecules bind the DNA. In this study, we used short EMSA probes that contained only 
the six RctB binding sites (or three binding sites respectively) from OriCII and no extra 
DNA. The difference between the binding affinity of the monomeric RctB and the wild 
type RctB was not clear when the longer probe was used; the difference in the apparent 
Kd was on the order of magnitude of the error. Surprisingly, when the shorter probe 
containing just the six RctB binding sites was used it resulted in an overall lower affinity 
of binding; however, it became obvious that monomeric RctB mutants (RctB-D314P and 
truncated RctB-1-499-D314P) bind this probe tighter than RctB wild type (and truncated 
dimeric RctB-1-499 respectively) (Figures 3.1 and 3.2, supplementary figure S 3.1). The 
observation that the monomeric RctB-D314P has higher affinity to the DNA probes with 
binding sites from the OriCII than wild-type RctB suggests that there is an additional step 
that the dimeric RctB has to undergo prior to binding the OriCII, which presumably is the 
dissociation of the RctB dimers to monomers.    
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Figure 3.1. Comparison of the affinities of the dimeric RctB-1-499-DNA interaction and 
monomeric RctB-1-499-D314P-DNA interaction. A and B. Comparison of RctB-1-499 and RctB-1-499-
D314P binding to DNA probe with three binding sites. On each gel the left side shows titration of RctB-1-
499, and the right side shows titration of the RctB-1-499-D314P, that allows comparison of electrophoretic 
mobility of the resulting complexes on gel B. RctB-1-499-D314P starts binding at lower concentrations and 
forms full complex at lower concentrations. Kdapp for RctB-1-499 is 520 nM, Kdapp for RctB-1-499-
D314P is 25 nM. The monomeric mutant binds about 20-fold tighter. C and D. Comparison of RctB-1-499 
and RctB-1-499-D314P binding to DNA probe with six binding sites. On each gel the left side shows 
titration of RctB-1-499, and the right side shows titration of the RctB-1-499-D314P. RctB-1-499-D314P 
starts binding at lower concentrations and forms full complex at lower concentrations. Kdapp for RctB-1-




Figure 3.2. Comparison between electrophoretic mobility of complexes formed by dimeric 
and monomeric RctB constructs. Note that in all the experiments the protein concentration range for the 
dimeric and monomeric proteins is different, because monomeric proteins have higher affinity to the DNA 
probes. A. RctB-1-499 and RctB-1-499-D314P form three distinct complexes when binding to the DNA 
probe with three RctB binding sites. The corresponding complexes have the same electrophoretic mobility. 
B. RctB-1-499 and RctB-1-499-D314P form six different complexes when binding to DNA probe with six 
binding sites. Electrophoretic mobility of the corresponding complexes formed by RctB-1-499 and RctB-1-
499-D314P is the same. C. RctB and RctB-D314P form three distinct complexes, and a species staying in 
the well, when binding to the DNA probe with three RctB binding sites. Electrophoretic mobility of the 
corresponding complexes formed by RctB and RctB-D314P is the same. D. RctB and RctB-D314P bind a 
DNA probe with six binding sites with high degree of cooperativity and the intermediate complexes can 
hardly be observed. 
 
Moreover, when complexes formed by wild type RctB and monomeric RctB (the 
intermediate species and the fully occupied probe) were run on the same exact retardation 
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gel, the resulting species had the same mobility (Figure 3.2). This suggests that RctB 
behaves similarly to plasmid initiators, and we could not observe it using the longer 
probe. The results of the EMSAs with the shorter probe could potentially be explained in 
the following way: monomeric RctB starts binding at lower concentrations than the wild 
type RctB, because monomers are already pre-formed, and the intermediate species 
formed by the RctB wild type and the monomeric mutant are in fact the same since they 
have the same mobility. To prove that this explanation is indeed correct, additional 
experiments are required. However, the aforementioned EMSAs are an important 
indicator that the hypothesis about RctB monomerization is likely to be true. 
In order to test whether in the context of a larger complex one RctB molecule 
binds one RctB binding site, we reconstructed in vitro a RctB-DNA complex with 3 
binding sites. The DNA probe with three binding sites was chosen because three is an 
odd number and if we observe three RctB molecules on DNA, this will allow easier 
interpretation of the experimental results, i.e. the observed masses. Using a short probe 
containing three RctB binding sites we were able to reconstruct a complex with a 
monomeric RctB mutant and detect it via native mass spectrometry. In the case of RctB-
499-D314P, when 1 uM of DNA (probe with three sites) was mixed with 4 uM of RctB 
(1.33 fold protein excess), we observed 2 species: 2RctB-499-D314P:1DNA and 3RctB-
499-D314P:1DNA. The 3RctB-499-D314P:1DNA complex was slowly falling apart 
during electrospray. When full-length RctB-D314P was used with the same ratio (excess 
protein), 2 species were observed: 3RctB-D314P:1DNA (major species) and 4RctB-
D314P:1DNA (Figure 3.3). It demonstrates that monomeric RctB-D314P can form a 
complex with 3 proteins on the DNA with 3 binding sites, and also that the complex with 
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the full-length RctB (that has the fourth domain unlike RctB-1-499-D314P) is more 
stable. Indeed, the fourth protein molecule can bind to the complex, presumably getting 
attached to the small excess of DNA, being held together by protein-protein interactions 
between domains four of adjacent molecules. 
 
Figure 3.3. Native mass spectrometry analysis of in vitro reconstructed protein-DNA 
complexes. A. RctB-1-499-D314P when mixed at slight excess with a DNA probe with three binding sites 
forms 2 species: 3RctB-1-499-D314P:1DNA and 2RctB-1-499-D314P:1DNA. B. RctB-D314P when 
mixed at slight excess with a DNA probe with three binding sites forms 2 species: 3RctB-1-499-
D314P:1DNA and 4RctB-1-499-D314P:1DNA. RctB-D314P when mixed at a 1 to 1 ratio with a DNA 




However, we were not able to reconstitute the 3RctB:1DNA complex using RctB 
wild type; we only observed the 2RctB:1DNA species that presumably was an original 
dimer binding DNA. This can be explained as follows: native mass spectrometry requires 
relatively high concentrations (relative to the concentrations used in EMSAs for 
example), and close to 1:1 ratios of the components, a large excess of either one would 
not produce data that can be interpreted. Therefore, the conditions that are required for 
native mass spectrometry analysis might be incompatible with the conditions required for 
RctB wild type monomerization; these exact conditions remain unclear. Attempts of 
native mass spectrometry experiments with the DNA probe containing six binding sites 
did not produce readable spectra, most likely because there was a mixture of species 
(6RctB-D314P-1DNA, 5RctB-D314P-1DNA, 4RctB-D314P-1DNA, etc) that could not 
be resolved. Even though native mass spectrometry experiments were not as insightful as 
we hoped, the experiments with the three-site DNA probe and RctB-1-499-D314P 
suggest that the full complex that we observed in EMSAs (with the same probe and 
protein) is 3proteins-1DNA. Accordingly, the two intermediate species are 1protein-
1DNA, and 2proteins-1DNA respectively, which helps the interpretation of the EMSA 
gels (Figure 3.2).  
3.4.2 THE FUNCTION OF THE C-TERMINAL DOMAIN 
Truncated RctB that is missing the C-terminal domain is capable of replication; 
however, there are two possible roles that the C-terminal domain could play. It was 
proposed that the C-terminal domain of RctB is important for binding to alternative DNA 
sites, apart from the 12-mers in the inc region (regulatory region) within OriCII (35,37). 
This suggests that the C-terminal domain could be involved in the regulation of DNA 
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replication via mediating RctB binding to regulatory binding sites. The other potential 
role can be proposed based on the comparison of the binding patterns of wild type RctB 
and truncated RctB (missing the C-terminal domain) to the OriCIImin probe. Wild type 
RctB binds the OriCIImin probe with a high degree of cooperativity; which can be 
concluded since no intermediate complexes are observed in previous EMSAs. 
Furthermore, only two outcomes are observed: no binding or the complete final complex. 
In contrast, the truncated RctB, missing the C-terminal domain had all the intermediate 
complexes present (39). The previous comparison suggests that the C-terminal domain of 
RctB can form protein-protein interactions between the adjacent RctB molecules 
positioned on OriCII, resulting in stabilization of the complex and the cooperative 
binding that is observed in the case of wild-type RctB.  
In order to fill the gap in understanding the role of the C-terminal domain of RctB 
we first set out to determine the border of the stable domain 4 construct. Previously 
trypsin digestion and limited proteolysis in the crystallization drop revealed the borders 
of domains 1 and 2-3 of RctB; however, under these conditions, domain 4 was digested 
and the domain border could not be identified. Secondary structure prediction software 
helped to identify a potentially long flexible linker in the beginning of the expected C-
terminal domain of RctB (Figure 3.4). Then, limited proteolysis of an available RctB C-
terminal construct (RctB-485-658-C-His, which failed to crystallize) was performed with 
different proteases, and the results of chymotrypsin digestion appeared to be consistent 
with a prediction of a 21 amino acid linker (Figure 3.5). Therefore, based on the 
secondary structure prediction and limited proteolysis information, the new construct for 









Figure 3.5. Limited proteolysis of the C-terminal portion of RctB (RctB-485-658). Limited proteolysis 
experiments with chymotrypsin and subtilisin demonstrated that upon proteolysis stable species with the 
mass of 15-18 kDa were formed. 
 
This protein construct easily crystallized and its structure was solved using X-ray 
crystallography (Figure 3.6). Two crystal forms were obtained, one had one molecule in 
an asymmetric unit and the other had two molecules in an asymmetric unit. All the crystal 
contacts in both molecules were inspected in order to determine the buried surface area 
for each interaction. Only one dimerization interface has a buried surface area that could 
potentially be biologically relevant (1815 Å2, a value that could suffice for a biologically 
relevant interaction). However, this is a head-to-head dimerization, which is not 
consistent with a proposed head-to-tail interaction that would connect all the six proteins 
on the origin. It is also possible that the relevant protein-protein interaction interface was 
not captured in the available crystal forms. The C-terminal domain structure was 
structurally aligned to all the other structures form the PDB database, however, the Z-
sores for all the alignments are rather low (the highest Z-score is 4.9). Since analysis of 
the buried surface areas and the structural alignments did not provide a ready answer 
about the function of RctB’s C-terminal domain, it was necessary to design a set of C-
terminal domain mutants. Each mutant would have a 1-3 surface amino acid substitution, 
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with an aim to disrupt any possible protein-protein interactions, and/or affect potential 
protein-DNA interactions. The residues that were chosen for mutational analysis are 
shown in figure 3.7. The mutants are listed in supplementary table S 3.2 (expression 
vectors pNO053 through pNO072).   
 
Figure 3.6. Domain composition of RctB, and the structure of the C-terminal domain of 
RctB. A. The domain composition of RctB. Scissors indicate regions susceptible to limited proteolysis. 





Figure 3.7. The amino acids chosen for mutational analysis. A.  A cartoon representation of the 
X-ray structure of the C-terminal domain of RctB (RctB-528-658).  B. A ribbon representation of the RctB-
528-658 structure, the residues that were chosen for mutational analysis are shown as magenta sticks. 
 
The notion that the fourth domain of RctB plays a role in protein-protein 
interactions is being supported by our mass spectrometry data. Indeed we observed that if 
the truncated RctB-1-499-D314P was used in a reaction with the three-site probe, a 
limited number of complexes were observed: 3proteins:1DNA and 2proteins:1DNA. 
However, if the full-length RctB-D314P was used we observed 3proteins:1DNA and 
4proteins:1DNA, where the fourth RctB molecule was probably held in part by protein-
protein interactions between domains four of adjacent RctB molecules (Figure 3.3).   
Moreover, analysis of our SAXS data shows that for the truncated RctB 
constructs missing the fourth domain (RctB-1-499 and RctB-1-499-D314P), the Rg and 
molecular weight estimation are consistent on the entire range of concentrations used. 
The independence of Rg and the estimated molecular weight suggests that the samples 
are mono-disperse at the entire concentration range. However, analysis of the data for the 
full-length RctB constructs (RctB wild-type and RctB-D314P) showed that at 
concentrations above approximately 2 mg/ml, the Rg and the calculated molecular weight 
started to increase with concentration. This increase is likely to be caused by some sort of 
association of the protein molecules (Table 3.1, raw SAXS data are presented in 
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supplementary figure S 3.2). Guinier analysis did not detect significant aggregation of the 
full-length RctB constructs; however, there are probably some additional oligomers 
formed that affected the Rg and MW estimation. The effect of increasing Rg estimation is 
influenced by the presence of the fourth domain; this suggests that the C-terminal domain 
is involved in protein-protein interactions that promote the association. The conclusion 
derived from the SAXS data that the C-terminal domain is likely to be involved in 
protein-protein interactions is consistent with the native mass-spectrometry data and the 
EMSA data. The SAXS experiments have to be reproduced in order to establish that the 
observed phenomena are taking place consistently. 
The SAXS experiments allowed for reconstruction of the overall shape of the full-
length RctB molecule; however, the linkers that are missing in the available X-ray 
structures are rather large, which leaves room for uncertainty of the reconstruction. This 
reconstruction is shown in figure 3.8. The fit of the reconstruction into the molecular 
envelope generated using DAMMIF software is presented in supplementary figure S 3.3. 
The reconstruction emphasizes how large and complex the RctB molecule is; this 
complexity and size reinforces the idea of RctB’s multifunctional role being regulated in 
a myriad of forms. The SAXS data has to be reproduced in order to be more confident in 
the reconstruction. 
All the mutants that were designed in order to test our hypothesis about the 
function of the fourth domain of RctB have been cloned, expressed and purified. Two of 
the proteins (RctB-H572R-A573G-S576A and RctB-W590A-R592A-N595A) have 
demonstrated severe degradation during the purification process; therefore they were 
abandoned for future studies. 
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Table 3.1. Rg and molecular weight estimations from SAXS data for RctB wild-type, RctB-1-










RctB wild-type 0.4 47.9 182.4 At concentrations less than or equal to 2 
mg/ml, Rg and molecular weight 
estimations are consistent. The molecular 
weight estimation is close to the expected 
one – 152.8 kDa. However, at higher 
concentrations Rg and MW start 
increasing. For all the samples SD for Rg 
is 3.1 Å. The highest MW estimation 
differs from the expected by 43%. 
0.8 46.5 182.3 
1.7 47.9 180.1 
2 49.1 180.4 
3.4 50.0 187.0 
5 53.0 213.3 
6.7 56.0 217.8 
RctB-1-499 0.8 42.7 117.8 For all the samples SD for Rg is 0.99 Å. 
SD is 6.9 kDa for the MW estimation. 
Molecular weight estimation is close to the 
expected one 117.1 kDa. The highest MW 
estimation differs from the expected by 
16%. 
1 43.6 125.0 
1.7 42.9 118.9 
2 43.8 125.0 
3.3 43.4 124.6 
5 43.8 133.9 
6.6 43.9 134.0 




and the experiment 
has to be repeated. 
The presented 
results are for the 
reference. 
0.6 48.9 123.9 The RctB-D314P protein used in this 
experiment did not have sufficient purity, 
therefore these results have to be taken 
with caution, and presented just for a 
reference. This experiment will be 
repeated in the near future. However, the 
present experiment also demonstrated a 
tendency where the Rg and molecular 
weight estimation tend to rise dramatically 
with concentration. 
1 58.0 137.1 
1.2 52.7 130.9 
2 59.0 154.8 
2.4 54.6 146.9 
4.8 59.2 171.3 
5 64.2 179.1 
9.6 70.4 215.3 
RctB-1-499-
D314P 
0.3 32.6 55.6 For all the samples SD for Rg is 0.87 Å. 
SD is 3.3 kDa for the MW estimation. 
Molecular weight estimation is close to the 
expected one - 58.6 kDa. The most 
different MW estimation differs from the 
expected by 17%. 
 0.5 33.3 48.5 
 1 33.8 57.4 
 1.1 33.2 57.0 
 2 34.0 58.0 
 2.2 33.2 56.9 




Figure 3.8. The model of the full-length RctB based on SAXS data using the CORAL 
program. The available X-ray structures were modeled to reconstruct the full-length RctB molecule based 
on the small-angle X-ray scattering data. Chi squared for the fit is 2.9843. The linkers missing in the X-ray 
structures are modeled as spheres. Domains are color-coded as follows: domain 1 – cyan, domain 2 – 
purple, domain 3 – orange, domain 4 – green.  
 
As mentioned earlier, in the previous study all the EMSA probes contained RctB 
binding sites embedded in a large piece of extra DNA. In this study, we were aiming to 
use the shortest probes possible. Using the shorter probe containing six RctB binding 
sites “12-mers”, resulted in an overall lower binding affinity; however, this allowed us to 
make very important observations. To study the interaction of RctB and the regulatory 
binding site, the 39-mer, we aimed to use the same approach – shorten the probe. 
Unfortunately, EMSAs with a double-stranded oligo containing just the 39 base pairs (the 
shortest probe possible) did not demonstrate any significant binding. It remains unclear 
why shortening of the EMSA probes results in a significant modification of the binding 
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affinity. This question is yet to be resolved. In spite of this in our studies we are planning 
to return to the original 39-mer probe, that contained the 39-mer binding site embedded 
in the longer DNA molecule. Using this probe, we are planning to test how all the 
purified eighteen mutants will compare to wild-type RctB in binding to the 39-mer site.  
All the eighteen mutants will be compared to the RctB wild-type in binding to the probe 
with the six 12-mers as well, to assess the effect of these mutations on the protein-protein 
interactions between RctB molecules. 
3.5 DISCUSSION 
The analysis of the available data allowed us to develop a hypothesis about the 
function of the C-terminal domain of RctB. The two proposed roles of domain four of 
RctB are: protein-protein interactions stabilizing the RctB-OriCII complex, and the 
involvement in binding of the regulatory RctB binding sites, such as 39-mer. Our native 
mass-spectrometry, EMSA and SAXS data together suggest the role of RctB in protein-
protein interactions is likely to be true. We solved the structure of the domain four of 
RctB and designed, cloned, expressed and purified mutants that will allow us to test the 




3.6 SUPPLEMENTARY DATA 
  
Figure S 3.1.  Comparison of the binding affinities of the RctB-1-499 and RctB-1-499-D314P to 
DNA probes. In both cases the binding affinity of the monomeric RctB-1-499-D314P is higher than the 
affinity of the dimeric RctB-1-499. 




Figure S 3.2. Raw SAXS data. The graphs Log(I) vs q are presented for the four proteins. For 
each protein there are several curves, which correspond to measurements for the samples with different 







Figure S 3.3. The RctB model fit into the molecular envelope. The reconstruction obtained 
using the CORAL program was manually fit into the envelope generated using DAMMIF program. There 




Supplementary table 3.1. Data collection, phasing and refinement statistics for SAD (SeMet) 
structure and the structure obtained with molecular replacement. 
   RctB-528-658 
(SAD) 
 RctB-528-658 
 (molecular replacement) 
Data collection      
Space group   P31 1 2  P 21 
Cell dimensions        
    a, b, c (Å)   46.77, 46.77, 118.84  43.58, 64.24, 47.42 
    a, b, g  (°)   90, 90, 120  90, 90.816, 90 
      
Wavelength   0.9791 (peak)  1.195 
Resolution (Å) 
 
  1.5 (CC1/2  = 0.946)   2.0 (CC1/2  = 0.971) 
Highest resolution shell 
 
  1.53 – 1.50  2.03-2.00 
Rsym all data (in highest 
resolution shell) 
 
  0.034 (0.184)  0.05 (0.105) 
<I / sigI> all data (in 
highest resolution shell) 
 
  39.3 (6.74)  41.49 (11) 
Completeness (%) all 
data (in highest 
resolution shell) 
 
  96.8 (89.4)   81.7 (31.3) 
Average redundancy all 
data (in highest 
resolution shell) 
  3.0 (2.9)   3.8 (2.4) 
      
Refinement      
Resolution (Å)   1.5  2.0 
No. reflections   23711  14386 
Rwork / Rfree   0.198/0.220  0.181/0.220 
No. atoms      
    Protein   999  2038 
    Water   219  249 
          
B-factors      
    Protein   19.29  23.82 
    Water   32.69  30.30 
          
R.m.s deviations      
    Bond lengths (Å)   0.004  0.002 
    Bond angles (°)   0.68  0.43 
Ramachandran plot 
statistics (MolProbity) 
     
Ramachandran favored   95.97%  96.43% 
Outliers   0%  0% 
PDB code   XXXX  YYYY 
SBGrid DataBank ID       
      
 
By default the resolution was determined using CC0.5 > 0.5 criteria; however, for both structures, at the chosen 
resolution limit CC0.5 is much greater than 0.5, but the incompleteness of data beyond the chosen resolution due to the 
detector position had to be taken into account as well. For RctB-528-658 (molecular replacement) completeness in 





Supplementary table 3.2. Plasmids. 




pET28b Protein expression  (35) 
pYB355 RctB-1-499-
C-His 













pET28b Protein expression  Waldor lab 
pNO052 RctB-528-
658 







































































































































pET28b Protein expression RctB-V630A-R632A-for, 
RctB-V630A-R632A-rev 




































pET28b Protein expression RctB-Y600A-for, RctB-
Y600A-rev 



















































































Supplementary table 3.3. Primers. 
 


















































Supplementary table 3.4. EMSA probes. 
 














CHAPTER 4 – CONCLUSIONS 
In conclusion, the research presented in this dissertation was focused on the 
elucidation of the structural and biochemical aspects of DNA replication initiation of the 
secondary chromosome in Vibrio cholerae. V. cholerae is a bacterial species that unlike 
most of bacteria has two chromosomes. DNA replication initiation of the secondary 
chromosome in V. cholerae requires a unique initiator protein, RctB, which is not similar 
in its amino acid sequence to any other protein.  We aimed to collect structural 
information in order to reveal the mechanism of bacterial DNA replication initiation, 
using the secondary V. cholerae chromosome as a system of interest.  
RctB is a 75 kDa protein. Domain composition of RctB was determined and the 
structures of all four domains of RctB were solved using X-ray crystallography. The 
structure of its central two domains resembles that of several plasmid replication 
initiators. We demonstrated that RctB contains at least three DNA binding domains, and 
integrity of each one of them is required for biological activity of RctB. In the structure, 
RctB adopts a head-to-head dimeric configuration that most likely represents the 
arrangement in solution. We hypothesize that RctB has to monomerize prior to binding 
the replication origin. We showed that the affinity of monomeric RctB to OriCII is 
higher, than the affinity of the wild-type dimeric protein, which suggests that the 
availability of the pre-formed monomers promotes OriCII binding.  We also showed that 
both wild-type and monomeric RctB-D314P form intermediate protein-DNA complexes 
with the same exact electrophoretic mobility, which suggests that the assembly of the 
RctB-OriCII complex goes through the same intermediates regardless of the original 
oligomeric state of RctB. 
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The similarity of RctB’s middle core and plasmid initiators support the hypothesis 
that the second Vibrionaceae chromosome could have evolved from a plasmid, and that 
RctB could acquire additional regulatory features. The structural information about the 
key three RctB domains and the information about the domains’ functions allowed us to 
develop a model of a complete assembly that RctB forms on the replication origin.  
The structure of the domain four of RctB was solved with X-ray crystallography 
as well. There are two working hypotheses about the domain four function: it was 
proposed to mediate RctB interaction with the regulatory binding sites (39-mer, rctA39-
mer, 29-mer), and it is proposed to mediate protein-protein interactions between adjacent 
RctB molecules within the large RctB-OriCII complex. The work dedicating to testing 
our hypothesis about domains four function is currently in progress and it is discussed in 







CHAPTER 5 – FUTURE DIRECTIONS 
 
The work described in this dissertation produced the first structural view for the 
secondary chromosomal DNA replication initiation machinery and laid out a strong 
foundation for future structural studies of the RctB-OriCII complexes.  The structural and 
biophysical data obtained in the course of this work allowed us to develop a model of the 
macromolecular complex; in which several molecules of RctB form on the replication 
origin of the secondary V. cholerae chromosome.  
The RctB structure provided greater understanding of the initiator function and 
allowed us to design a monomeric RctB mutant. Using monomeric RctB protein (RctB-
D314P), we were able to obtain stable macromolecular RctB-DNA complexes. 
Therefore, the main future direction of this research is to obtain a high-resolution 
structure of the RctB-OriCII complex using cryo-EM.  
The ability to prepare a suitable stable sample is a key obstacle for any structural 
study; the fact that the RctB structure provided us with the tools to obtain stable protein-
DNA complexes is extremely encouraging. There is no available high- or low-resolution 
structure of a macromolecular assembly formed on E. coli’s main chromosome or an 
assembly formed on the plasmid replication origin. Therefore, if the structure of the 
complete assembly formed on the origin DNA by RctB would be elucidated, it would 
become the first structure of bacterial replication origin-initiator complex. Obtaining a 
premier view of the complete initiator-origin DNA assembly would be a huge milestone 
for the understanding of the mechanistic details of bacterial DNA replication initiation. 
The future EM work will include pursuing structures of several RctB-DNA 
complexes in parallel: a DNA probe with 3 RctB binding sites (half of OriCII-min) and 
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RctB, a DNA probe with 6 RctB binding sites (all the RctB binding sites from OriCII-
min) and RctB, a DNA probe with 6 RctB binding sites (all the RctB binding sites from 
OriCII-min), the DnaA binding site, RctB, and DnaA, and other probes. The structures of 
the smaller complexes would provide information about the RctB-RctB contacts and 
prove or adjust our hypothesis about the symmetry of RctB binding to origin DNA; 
structures of the larger complexes would shed light on the mechanism of the unwinding 
of the DNA double helix, such a complex should contain the complete OriCII-min 
including the AT-rich region. 
Another important direction of the project is the determination of a full RctB 
binding site. It is reported that OriCIImin has six conserved 12-mers, which are 
considered to be RctB binding sites. However, our structural studies suggest that the full 
RctB binding site has to be larger than a 12-mer and include some of the spacer DNA, 
forming a binding site of about 22 basepairs long. Determination of the full RctB binding 
site will clarify the mode of RctB interaction with DNA. Importantly, determination of 
the complete RctB binding site would allow us to pursue the structure determination of a 
single RctB-DNA complex via x-ray crystallography.  
One of the main obstacles for crystallization of protein-DNA complexes is the 
determination of the appropriate DNA molecule; therefore, determination of the RctB 
binding site would allow us to start the crystallization efforts for the RctB-DNA complex. 
Our preliminary data with unmethylated DNA suggests that the full RctB binding site 
includes the conserved 12-mer plus about 10 basepairs to the right of the conserved 12-
mer. These results have to be reproduced in the same conditions and also reproduced with 
methylated DNA, since RctB binds to methylated binding site with grater affinity, and 
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methylation of the 12-mers is required for RctB function in vivo. If these results prove to 
be reproducible, crystallization trials with the DNA molecule containing the minimal 
binding site will promptly be pursued. 
Another important direction is investigation of the interaction between RctB-
OriCIImin complex and single-stranded DNA. The working hypothesis implies that when 
RctB forms a macromolecular complex on OriCIImin a new surface with affinity to 
single-stranded DNA forms, and that surface binds one of the strands of the AT-rich 
region. The described mechanism is proposed for the E. coli DnaA based replication 
system, and we hypothesize that the RctB-based replication system operates using a 
similar mechanism. In order to test this hypothesis, EMSAs with radiolabeled single-
stranded DNA from an A-T rich region will be used. Ultimately, a high-resolution EM 
structure of OriCIImin-RctB complex bound to a single-stranded DNA (if such indeed 
forms) would provide the most important mechanistic details of the DNA replication 
initiation mechanism. 
Lastly, there is a very important and interesting feature of the secondary 
chromosomal replication that is missing structural details; the coordination in timing 
between the primary and the secondary chromosomal replication. It was shown that the 
coordinated replication depends on the RctB binding site that is located on the primary V. 
cholerae chromosome (cit). It is hypothesized that RctB binds to both chromosomes and, 
therefore, brings them together, which in turn triggers coordinated DNA replication 
initiation. However, current understanding of this mechanism is very limited. It is very 
important to elucidate the structural and mechanistic details of such a unique and 
elaborate regulatory mechanism.  
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In conclusion, the work described in this dissertation laid out a strong foundation 
for in depth structural studies of the structural aspects of DNA replication initiation of the 
secondary chromosome in V. cholerae. Obtaining a first view of the complete initiator-
origin DNA assembly is one of the key directions for future work and it would provide 
understanding of the mechanistic details of bacterial DNA replication initiation.  
Determination of the minimal RctB binding site and obtaining a DNA-bound 
RctB structure would help to validate our hypothesis about RctB-OriCII interactions. 
Experiments with the RctB-OriCII complexes and single-stranded DNA from the A-T 
rich region would reveal the mechanism of DNA melting. Finally, elucidation of the 
coordination between the replication of the two chromosomes would provide 
understanding of the specific features unique to multi-chromosomal bacteria. The 
knowledge about the coordinated replication would contribute greatly to our 
understanding of DNA replication mechanism in bacteria and, in particular, in multi-
chromosomal bacteria. 
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